To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STK25TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
875 supporting clones for gene STK25 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG332055 large cell carcinoma, lung .a -8 to 810 1 to 835   tiling clone,   788/894
(88 %)
50 diff
(94.5 %id)
BI465164 testis .a 4 to 770 1 to 774       774/780
(99 %)
30 diff
(96.2 %id)
BQ937350 epidermoid carcinoma, cell line, lung .a 31 to 892 1 to 865   tiling clone,   865/866
(99 %)
7 diff
(99.2 %id)
AA297553 Kidney .a 559 to 820 1 to 262       262/262
(100 %)
0 diff
(100 %id)
TI_1948128693   .a 596 to 1502 1040 to 130   tiling clone,   910/1117
(81 %)
36 diff
(96.8 %id)
CR978881 T-Lymphocytes .b 1 to 314 3 to 317   tiling clone,   317/324
(97 %)
3 diff
(99.1 %id)
CR982110 T-Lymphocytes .b 48 to 294 1 to 247       247/257
(96 %)
1 diff
(99.7 %id)
CN286209 embryonic stem cells, cell lines H1, H7, andH9 .b 229 to 411 1 to 183       183/183
(100 %)
1 diff
(99.5 %id)
BI547498 brain, hippocampus .b 253 to 839 1 to 598       598/598
(100 %)
20 diff
(96.7 %id)
TI_44168287   .b 256 to 839 86 to 680       595/680
(87 %)
13 diff
(98.1 %id)
BU541010 epithelioid carcinoma cell line, Pancreas .b 258 to 1010 1 to 758       758/917
(82 %)
16 diff
(98.3 %id)
CB045383 colon, juvenile granulosa tumor .b 260 to 710 1 to 451       451/451
(100 %)
5 diff
(98.9 %id)
BU517254 leiomyosarcoma, uterus .b 263 to 1009 1 to 748       748/875
(85 %)
7 diff
(99.2 %id)
BG830582 epithelioid carcinoma cell line, Pancreas .b 265 to 927 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
BG830637 epithelioid carcinoma cell line, Pancreas .b 265 to 773 1 to 520       520/909
(57 %)
22 diff
(97.6 %id)
TI_57197325   .b 268 to 1009 50 to 791       742/798
(92 %)
13 diff
(98.4 %id)
AL536459 brain, fetal brain .b 271 to 1117 1 to 843       843/843
(100 %)
6 diff
(99.3 %id)
BI765030 pooled colon, kidney, stomach .b 272 to 915 1 to 644       644/644
(100 %)
4 diff
(99.4 %id)
TI_57152919   .b 272 to 915 28 to 671       644/671
(95 %)
8 diff
(98.9 %id)
BM763032 myeloma .b 276 to 878 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM763276 myeloma .b 276 to 900 1 to 625       625/632
(98 %)
2 diff
(99.7 %id)
BM848294 myeloma .b 276 to 687 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BU845484 ovary, teratocarcinoma, cell line .b 279 to 902 1 to 628       628/914
(68 %)
12 diff
(98.7 %id)
BU557016 ovary, teratocarcinoma, cell line .b 279 to 1010 1 to 731       731/975
(74 %)
21 diff
(97.9 %id)
BU849142 ovary, teratocarcinoma, cell line .b 279 to 934 1 to 666       663/877
(75 %)
15 diff
(98.3 %id)
BU854782 ovary, teratocarcinoma, cell line .b 279 to 1071 1 to 796       796/909
(87 %)
9 diff
(99.1 %id)
BU855259 ovary, teratocarcinoma, cell line .b 279 to 1008 1 to 735       735/922
(79 %)
9 diff
(99.1 %id)
BM550024 astrocytoma grade IV, cell line, brain .b 280 to 1168 31 to 922       892/1068
(83 %)
15 diff
(98.6 %id)
AL564539 brain, fetal liver, Liver, neuroblastoma cells .b 282 to 1167 1 to 884       884/884
(100 %)
22 diff
(97.6 %id)
BI819437 pooled brain, lung, testis .b 283 to 1009 1 to 727       727/734
(99 %)
7 diff
(99.1 %id)
TI_44346028   .b 283 to 1026 83 to 826       744/826
(90 %)
6 diff
(99.3 %id)
BG714083 brain, hypothalamus .b 284 to 792 1 to 529       529/772
(68 %)
33 diff
(95.8 %id)
BI457652 brain, hypothalamus .b 284 to 1125 1 to 836       833/839
(99 %)
20 diff
(97.7 %id)
BI669309 brain, hypothalamus .b 284 to 1026 1 to 743       743/743
(100 %)
5 diff
(99.4 %id)
BG747837 eye, normal pigmented retinal epithelium .b 286 to 994 1 to 733       733/733
(100 %)
31 diff
(95.8 %id)
BG753305 eye, normal pigmented retinal epithelium .b 286 to 1002 1 to 725       725/728
(99 %)
12 diff
(98.4 %id)
BM910582 astrocytoma grade IV, cell line, brain .b 286 to 1078 1 to 797       797/1037
(76 %)
9 diff
(99.2 %id)
AL521704 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 304 to 1219 1 to 905       905/911
(99 %)
20 diff
(97.9 %id)
BG824755 adenocarcinoma cell line, colon .b 311 to 847 1 to 572       567/1054
(53 %)
29 diff
(97.3 %id)
BC015793 Colon, adenocarcinoma .b 312 to 2505 1 to 2194 K374E tiling clone, available from MGC, AAA   2194/2194
(100 %)
1 diff
(100.0 %id)
BM041119 Kidney, Wilms' tumor, cell line .b 325 to 963 1 to 658       656/660
(99 %)
27 diff
(96.0 %id)
AA199683   .b 327 to 582 1 to 255       255/262
(97 %)
14 diff
(94.7 %id)
TI_159677996   .b 330 to 1075 55 to 800       743/1057
(70 %)
26 diff
(97.6 %id)
BF312837 brain, neuroblastoma .b 362 to 1142 1 to 786       783/1053
(74 %)
18 diff
(98.3 %id)
BF317249 brain, neuroblastoma .b 362 to 969 1 to 632       597/864
(69 %)
35 diff
(96.0 %id)
BM804217 eye, retinoblastoma .b 364 to 1009 1 to 646       646/1112
(58 %)
3 diff
(99.8 %id)
BE868871 adenocarcinoma, colon .b 383 to 1067 1 to 700       697/863
(80 %)
14 diff
(98.4 %id)
BI911252 leukocyte .b 405 to 1132 30 to 767       738/769
(95 %)
16 diff
(98.0 %id)
TI_57232041   .b 405 to 1132 30 to 767       738/769
(95 %)
16 diff
(98.0 %id)
DA033522   .b 434 to 1004 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA912960   .b 435 to 1006 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BM809918 astrocytoma grade IV, cell line, brain .b 436 to 1310 27 to 904       878/1180
(74 %)
25 diff
(97.9 %id)
DA695942   .b 444 to 988 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
X99325   .b 455 to 2428 1 to 1969 E347D P348A     1969/1975
(99 %)
17 diff
(99.2 %id)
CF131828 Chondrosarcoma Lung Metastasis cell lines, lung .b 463 to 873 1 to 411       411/411
(100 %)
1 diff
(99.8 %id)
BF568494 epithelioid carcinoma cell line, Pancreas .b 571 to 1013 384 to 824       596/1030
(57 %)
35 diff
(96.7 %id)
AL521703 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 1506 to 2483 976 to 1       976/976
(100 %)
11 diff
(98.9 %id)
AL564466 brain, fetal liver, Liver, neuroblastoma cells .b 1533 to 2469 936 to 1   tiling clone,   936/936
(100 %)
15 diff
(98.4 %id)
AL566342 brain, fetal brain .b 1568 to 2455 905 to 12       894/905
(98 %)
6 diff
(99.4 %id)
BM041624 Kidney, Wilms' tumor, cell line .b 1613 to 2442 840 to 10       831/863
(96 %)
3 diff
(99.7 %id)
BF568814 epithelioid carcinoma cell line, Pancreas .b 1698 to 2432 780 to 29       752/1205
(62 %)
15 diff
(98.8 %id)
CB045382 colon, juvenile granulosa tumor .b 2099 to 2507 439 to 31   tiling clone, AAA   409/409
(100 %)
2 diff
(99.6 %id)
DB212137 trachea .c 1 to 535 2 to 536   tiling clone, capped   535/535
(100 %)
0 diff
(100 %id)
DB162651 thymus .c 59 to 640 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BC007852 Uterus, leiomyosarcoma .c 69 to 2208 1 to 2140 exact tiling clone, available from MGC, AAA   2140/2140
(100 %)
0 diff
(100 %id)
BF683217 leiomyosarcoma cell line, uterus .c 69 to 719 1 to 685       681/950
(71 %)
65 diff
(93.2 %id)
NM_006374.3   .c 69 to 2208 1 to 2140 exact RefSeq, AAA   2140/2140
(100 %)
0 diff
(100 %id)
TI_45210577   .c 71 to 948 88 to 966   AAA   879/980
(89 %)
21 diff
(97.9 %id)
BI600595 brain, hypothalamus .c 72 to 952 1 to 878       878/906
(96 %)
21 diff
(97.7 %id)
DA263376 caudate nucleus .c 73 to 621 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BI826270 brain, medulla .c 73 to 944 1 to 880       880/880
(100 %)
14 diff
(98.5 %id)
TI_57173352   .c 73 to 944 91 to 970       880/970
(90 %)
18 diff
(98.2 %id)
DB270665 uterus .c 76 to 494 2 to 420   capped   419/419
(100 %)
2 diff
(99.6 %id)
DA999413 breast, tumor tissue .c 78 to 614 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DB188745 liver, tumor tissue .c 78 to 648 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DB048259 testis .c 79 to 635 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA574498   .c 80 to 637 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA033713   .c 82 to 646 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BI255718 cervical carcinoma cell line, cervix .c 82 to 444 1 to 372       372/372
(100 %)
17 diff
(95.5 %id)
DA718950   .c 82 to 610 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
DA039401 bladder .c 88 to 666 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BI085485 astrocytoma grade IV, cell line, brain .c 92 to 868 1 to 786       786/957
(82 %)
19 diff
(98.1 %id)
BM019402 astrocytoma grade IV, cell line, brain .c 92 to 819 1 to 732       732/733
(99 %)
9 diff
(98.8 %id)
BM554445 brain, medulla .c 92 to 1108 1 to 1019       1019/1023
(99 %)
20 diff
(98.1 %id)
TI_59390083   .c 93 to 819 64 to 794       731/732
(99 %)
8 diff
(99.0 %id)
BM908976 astrocytoma grade IV, cell line, brain .c 94 to 869 1 to 777       777/1109
(70 %)
8 diff
(99.3 %id)
DA839375 placenta .c 94 to 638 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
TI_57243961   .c 99 to 846 26 to 785       760/894
(85 %)
19 diff
(97.9 %id)
DA351377 substantia nigra .c 100 to 684 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
AU279955   .c 102 to 661 1 to 561       561/561
(100 %)
5 diff
(99.2 %id)
CD300708 testis .c 102 to 627 11 to 545       535/813
(65 %)
23 diff
(97.2 %id)
DB263809 uterus .c 103 to 691 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
AK291947   .c 104 to 1625 1 to 1522 exact     1522/1522
(100 %)
0 diff
(100 %id)
DA444977 tongue, tumor tissue .c 104 to 660 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
AU099570   .c 104 to 403 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
BP264735 umbilical vein .c 104 to 659 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
DA150754 amygdala .c 105 to 675 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DT216234 brain .c 105 to 729 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
DA652154   .c 105 to 663 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA844749 placenta .c 105 to 589 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
DA906965   .c 105 to 687 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB155081 thymus .c 105 to 585 2 to 482   capped   481/486
(98 %)
2 diff
(99.6 %id)
DB163302 thymus .c 105 to 660 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA071400 cerebellum .c 106 to 681 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA933539 Spleen .c 106 to 673 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
TI_57218838   .c 110 to 1013 59 to 964       906/966
(93 %)
32 diff
(96.7 %id)
ES313017 beard hair, skin .c 112 to 248 1 to 132       132/132
(100 %)
3 diff
(97.8 %id)
BM924074 pooled colon, kidney, stomach .c 112 to 1093 1 to 991       991/991
(100 %)
19 diff
(98.1 %id)
DA934591 Spleen .c 113 to 660 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BM920421 pooled lung and spleen .c 114 to 1054 19 to 971       953/1141
(83 %)
42 diff
(96.4 %id)
DA909969   .c 114 to 691 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
AL039545 testis .c 116 to 589 1 to 474       474/474
(100 %)
0 diff
(100 %id)
DA304923 hippocampus .c 119 to 703 2 to 586   capped   585/586
(99 %)
1 diff
(99.9 %id)
BI755528 brain .c 119 to 1013 1 to 898       898/900
(99 %)
26 diff
(97.2 %id)
BM908671 astrocytoma grade IV, cell line, brain .c 120 to 869 10 to 760       748/1142
(65 %)
25 diff
(97.9 %id)
BM558223 astrocytoma grade IV, cell line, brain .c 120 to 1025 1 to 917       917/1068
(85 %)
18 diff
(98.4 %id)
BQ277938 ovary, teratocarcinoma, cell line .c 120 to 710 24 to 616       593/1197
(49 %)
18 diff
(98.5 %id)
BU856246 ovary, teratocarcinoma, cell line .c 120 to 993 43 to 942       900/946
(95 %)
52 diff
(94.6 %id)
BM810504 astrocytoma grade IV, cell line, brain .c 121 to 1049 1 to 936       936/1071
(87 %)
12 diff
(98.9 %id)
BM910744 astrocytoma grade IV, cell line, brain .c 121 to 869 1 to 751       751/1069
(70 %)
9 diff
(99.2 %id)
BQ278138 ovary, teratocarcinoma, cell line .c 121 to 1021 1 to 908       908/1072
(84 %)
25 diff
(97.7 %id)
BU552845 ovary, teratocarcinoma, cell line .c 121 to 1009 1 to 889       889/898
(98 %)
13 diff
(98.6 %id)
BU844717 ovary, teratocarcinoma, cell line .c 121 to 993 1 to 876       876/877
(99 %)
16 diff
(98.2 %id)
BU855885 ovary, teratocarcinoma, cell line .c 121 to 1009 1 to 896       896/899
(99 %)
18 diff
(98.0 %id)
BU931539 ovary, teratocarcinoma, cell line .c 121 to 543 1 to 433       433/787
(55 %)
11 diff
(98.7 %id)
CX757726 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 121 to 845 1 to 724     Submitted on the opposite strand 724/724
(100 %)
6 diff
(99.2 %id)
DB448054 testis .c 126 to 518 1 to 393       393/393
(100 %)
1 diff
(99.8 %id)
BP252084 Kidney .c 126 to 731 1 to 606       606/606
(100 %)
6 diff
(99.1 %id)
BP307879 brain .c 126 to 713 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
DA850287 placenta .c 127 to 681 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BQ653706 hepatocellular carcinoma, cell line, Liver .c 128 to 824 11 to 709       699/836
(83 %)
27 diff
(96.8 %id)
BQ645902 hepatocellular carcinoma, cell line, Liver .c 128 to 1055 13 to 942       930/977
(95 %)
29 diff
(97.1 %id)
BQ652091 hepatocellular carcinoma, cell line, Liver .c 128 to 978 18 to 874       857/937
(91 %)
26 diff
(97.3 %id)
BQ653805 hepatocellular carcinoma, cell line, Liver .c 128 to 1003 18 to 890       873/890
(98 %)
24 diff
(97.4 %id)
AU122971   .c 128 to 709 10 to 591   capped   582/736
(79 %)
10 diff
(98.7 %id)
BQ648219 hepatocellular carcinoma, cell line, Liver .c 130 to 1078 1 to 946       946/947
(99 %)
22 diff
(97.7 %id)
BQ649788 hepatocellular carcinoma, cell line, Liver .c 130 to 977 1 to 851       851/851
(100 %)
5 diff
(99.5 %id)
BQ653093 hepatocellular carcinoma, cell line, Liver .c 130 to 1009 1 to 892       892/984
(90 %)
25 diff
(97.5 %id)
BQ650273 hepatocellular carcinoma, cell line, Liver .c 130 to 820 1 to 692       692/826
(83 %)
16 diff
(98.1 %id)
BQ647220 hepatocellular carcinoma, cell line, Liver .c 130 to 943 1 to 818       818/909
(89 %)
12 diff
(98.7 %id)
BQ650873 hepatocellular carcinoma, cell line, Liver .c 130 to 1009 1 to 898       852/935
(91 %)
44 diff
(95.3 %id)
BQ654016 hepatocellular carcinoma, cell line, Liver .c 130 to 946 1 to 819       819/884
(92 %)
7 diff
(99.3 %id)
BQ647894 hepatocellular carcinoma, cell line, Liver .c 130 to 1016 1 to 892       892/925
(96 %)
10 diff
(99.0 %id)
BQ649581 hepatocellular carcinoma, cell line, Liver .c 130 to 924 1 to 799       799/927
(86 %)
26 diff
(97.2 %id)
BQ647832 hepatocellular carcinoma, cell line, Liver .c 130 to 712 1 to 588       588/996
(59 %)
19 diff
(98.1 %id)
DA712466   .c 133 to 696 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BM020755 astrocytoma grade IV, cell line, brain .c 160 to 860 1 to 702       702/704
(99 %)
3 diff
(99.6 %id)
TI_59387778   .c 161 to 860 113 to 813       701/703
(99 %)
2 diff
(99.8 %id)
BM549892 astrocytoma grade IV, cell line, brain .c 163 to 1016 1 to 857       857/982
(87 %)
6 diff
(99.4 %id)
TI_154188647   .c 167 to 963 168 to 959       792/918
(86 %)
14 diff
(98.5 %id)
BG752090 eye, normal pigmented retinal epithelium .c 177 to 1013 1 to 832       832/879
(94 %)
20 diff
(97.8 %id)
BI917031 brain .c 178 to 819 109 to 776       680/776
(87 %)
68 diff
(91.3 %id)
TI_57242317   .c 178 to 819 143 to 810       680/810
(83 %)
68 diff
(91.7 %id)
D63780   .c 180 to 2204 11 to 2035 exact     2030/2035
(99 %)
8 diff
(99.7 %id)
BU158978 embryonal carcinoma, cell line, testis .c 189 to 1009 1 to 823       823/899
(91 %)
7 diff
(99.3 %id)
CF131976 Chondrosarcoma Lung Metastasis cell lines, lung .c 193 to 873 1 to 681       681/681
(100 %)
0 diff
(100 %id)
TI_159677689   .c 193 to 1046 51 to 900       850/1045
(81 %)
15 diff
(98.6 %id)
BQ962277 leiomyosarcoma, uterus .c 210 to 1014 1 to 808       808/901
(89 %)
14 diff
(98.5 %id)
BG386553 adenocarcinoma cell line, colon .c 218 to 869 1 to 660       660/762
(86 %)
16 diff
(98.0 %id)
DN994538 brain, whole brain .c 272 to 964 1 to 693       693/693
(100 %)
4 diff
(99.5 %id)
TI_1948077814   .c 283 to 1194 130 to 1044       915/1126
(81 %)
42 diff
(96.3 %id)
TI_1948077815   .c 283 to 1206 130 to 1053       922/1263
(73 %)
14 diff
(98.9 %id)
TI_1948078129   .c 283 to 869 131 to 716       586/1114
(52 %)
13 diff
(98.9 %id)
TI_1948078130   .c 283 to 1200 128 to 1046       919/1276
(72 %)
19 diff
(98.6 %id)
TI_1948078457   .c 283 to 995 132 to 843       712/1127
(63 %)
24 diff
(97.9 %id)
TI_1948078458   .c 283 to 1206 130 to 1057       928/1286
(72 %)
32 diff
(97.6 %id)
TI_1948078799   .c 283 to 1053 129 to 908       780/1147
(68 %)
33 diff
(97.2 %id)
TI_1948078800   .c 283 to 1203 127 to 1050       924/1248
(74 %)
32 diff
(97.5 %id)
TI_1948128350   .c 283 to 1054 129 to 896       768/1189
(64 %)
25 diff
(97.9 %id)
TI_1948128351   .c 283 to 1186 128 to 1038       911/1183
(77 %)
26 diff
(97.9 %id)
TI_1948129021   .c 283 to 1055 130 to 897       768/1164
(65 %)
28 diff
(97.6 %id)
TI_1948129022   .c 283 to 1155 127 to 1019       891/1223
(72 %)
33 diff
(97.4 %id)
BT019961   .c 284 to 1562 1 to 1279       1279/1281
(99 %)
1 diff
(100.0 %id)
CV027031 mixed .c 284 to 950 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
CV029033 mixed .c 284 to 941 1 to 657       657/657
(100 %)
3 diff
(99.6 %id)
AL046780 testis .c 287 to 880 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
AL534942 brain, fetal brain .c 308 to 1049 1 to 761       715/761
(93 %)
66 diff
(91.4 %id)
T08159   .c 364 to 750 1 to 386       386/387
(99 %)
3 diff
(99.3 %id)
AU117506 whole embryo, mainly head .c 473 to 1236 2 to 764   capped   763/765
(99 %)
2 diff
(99.8 %id)
BM724270 eye, fetal eye .c 480 to 1210 1 to 732       732/732
(100 %)
1 diff
(99.9 %id)
H22726 whole brain .c 571 to 1023 1 to 460       460/460
(100 %)
11 diff
(97.7 %id)
CB069082 Pancreas, Purified pancreatic islet .c 729 to 1116 1 to 388       388/389
(99 %)
2 diff
(99.5 %id)
BM694556 eye, RPE and Choroid .c 753 to 1103 1 to 351       351/351
(100 %)
1 diff
(99.8 %id)
F11376 brain, total brain .c 837 to 1144 1 to 308       308/308
(100 %)
0 diff
(100 %id)
TI_1948077817   .c 864 to 1563 826 to 127       700/1252
(55 %)
15 diff
(98.9 %id)
TI_1948078802   .c 864 to 1563 829 to 128       702/1231
(57 %)
14 diff
(98.9 %id)
TI_1948128022   .c 875 to 1563 814 to 125       690/1456
(47 %)
9 diff
(99.4 %id)
BU957231 adenocarcinoma, cell line, breast .c 881 to 1654 1 to 777       777/910
(85 %)
8 diff
(99.2 %id)
CF454927 peripheral nervous system .c 884 to 1644 1 to 761       761/761
(100 %)
4 diff
(99.5 %id)
BI859986 breast, mammary adenocarcinoma, cell line .c 922 to 1704 1 to 784       784/784
(100 %)
9 diff
(98.9 %id)
TI_57188723   .c 922 to 1704 56 to 839       784/784
(100 %)
9 diff
(98.9 %id)
TI_1948129023   .c 935 to 1563 755 to 126       630/1383
(45 %)
14 diff
(99.0 %id)
CN421603 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 945 to 1602 1 to 661       661/661
(100 %)
4 diff
(99.4 %id)
BU180486 epidermoid carcinoma, cell line, salivary gland .c 949 to 1890 1 to 942       942/942
(100 %)
8 diff
(99.2 %id)
BU197251 epidermoid carcinoma, cell line, salivary gland .c 949 to 1770 1 to 829       829/1001
(82 %)
29 diff
(97.2 %id)
BQ898293 epidermoid carcinoma, cell line, salivary gland .c 949 to 1736 1 to 792       792/899
(88 %)
9 diff
(99.0 %id)
BQ671806 epidermoid carcinoma, cell line, salivary gland .c 949 to 1641 1 to 703       703/854
(82 %)
25 diff
(97.1 %id)
BQ674611 epidermoid carcinoma, cell line, salivary gland .c 949 to 1824 1 to 886       886/918
(96 %)
21 diff
(97.8 %id)
BU838666 epidermoid carcinoma, cell line, salivary gland .c 949 to 1701 1 to 754       754/953
(79 %)
15 diff
(98.5 %id)
BQ672411 epidermoid carcinoma, cell line, salivary gland .c 949 to 1828 1 to 890       890/937
(94 %)
25 diff
(97.4 %id)
TI_1948128023   .c 956 to 1563 730 to 123       608/1065
(57 %)
18 diff
(98.4 %id)
BG747622 eye, normal pigmented retinal epithelium .c 957 to 1623 1 to 664       664/664
(100 %)
5 diff
(99.3 %id)
BQ953079 eye, normal pigmented retinal epithelium .c 962 to 1741 1 to 786       786/960
(81 %)
12 diff
(98.8 %id)
BE279567 choriocarcinoma, placenta .c 969 to 1571 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
BE902419 choriocarcinoma, placenta .c 969 to 1823 1 to 851       851/1066
(79 %)
35 diff
(96.8 %id)
BI869852 adenocarcinoma, cell line, Liver .c 969 to 1814 1 to 849       849/853
(99 %)
7 diff
(99.2 %id)
BQ651800 hepatocellular carcinoma, cell line, Liver .c 969 to 1741 1 to 783       783/990
(79 %)
11 diff
(98.9 %id)
TI_57228915   .c 969 to 1814 113 to 961       849/853
(99 %)
7 diff
(99.2 %id)
BE744968 adenocarcinoma cell line, ovary .c 976 to 1817 1 to 848       848/890
(95 %)
64 diff
(92.9 %id)
BG775639 carcinoma, cell line, Prostate .c 977 to 1418 1 to 442   fully sequenced,   442/442
(100 %)
1 diff
(99.8 %id)
BM048191 carcinoma, cell line, Prostate .c 977 to 1947 1 to 979       979/989
(98 %)
53 diff
(94.7 %id)
BM043719 carcinoma, cell line, Prostate .c 977 to 1620 1 to 643       643/643
(100 %)
5 diff
(99.3 %id)
BM044156 carcinoma, cell line, Prostate .c 977 to 1607 1 to 628       628/634
(99 %)
5 diff
(99.3 %id)
BM044693 carcinoma, cell line, Prostate .c 977 to 1818 1 to 859       703/860
(81 %)
17 diff
(98.1 %id)
BM049891 carcinoma, cell line, Prostate .c 977 to 1712 1 to 737       737/737
(100 %)
6 diff
(99.2 %id)
BM048847 carcinoma, cell line, Prostate .c 977 to 1874 1 to 914       914/948
(96 %)
35 diff
(96.4 %id)
BM046598 carcinoma, cell line, Prostate .c 977 to 1870 1 to 912       912/998
(91 %)
60 diff
(94.0 %id)
BE746072 adenocarcinoma cell line, ovary .c 978 to 1705 1 to 719       719/720
(99 %)
10 diff
(98.7 %id)
BQ927172 carcinoma, cell line, Prostate .c 980 to 1858 1 to 889       889/903
(98 %)
22 diff
(97.6 %id)
BQ920432 carcinoma, cell line, Prostate .c 980 to 1916 1 to 940       940/944
(99 %)
16 diff
(98.4 %id)
BE395907 endometrium, adenocarcinoma cell line, uterus .c 985 to 1577 1 to 593       593/594
(99 %)
1 diff
(99.9 %id)
BE261960 brain, neuroblastoma .c 1003 to 1590 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
BG180127 adenocarcinoma, cell line, Prostate .c 1003 to 1789 1 to 781       781/860
(90 %)
31 diff
(96.4 %id)
BE278206 choriocarcinoma, placenta .c 1018 to 1658 1 to 640       640/674
(94 %)
6 diff
(99.2 %id)
BQ931771 epidermoid carcinoma, cell line, lung .c 1019 to 1895 1 to 888       888/888
(100 %)
16 diff
(98.2 %id)
BG397335 B-cells, primary B-cells from tonsils (cell line) .c 1038 to 2001 1 to 957       957/963
(99 %)
32 diff
(96.7 %id)
BG398488 B-cells, primary B-cells from tonsils (cell line) .c 1038 to 1796 1 to 762       762/785
(97 %)
21 diff
(97.4 %id)
BG684863 B-cells, primary B-cells from tonsils (cell line) .c 1038 to 1697 1 to 663       663/663
(100 %)
8 diff
(98.8 %id)
TI_1948078460   .c 1055 to 1563 639 to 122       518/1146
(45 %)
38 diff
(96.7 %id)
TI_44384998   .c 1057 to 1794 48 to 798       751/962
(78 %)
35 diff
(96.4 %id)
CN421597 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1068 to 1674 1 to 607       607/607
(100 %)
4 diff
(99.4 %id)
TI_57247394   .c 1071 to 1981 36 to 947       912/964
(94 %)
13 diff
(98.7 %id)
CD622524   .c 1077 to 1560 1 to 484       484/484
(100 %)
0 diff
(100 %id)
CD622525   .c 1077 to 1746 684 to 15       670/684
(97 %)
0 diff
(100 %id)
BE245031 leukopheresis .c 1084 to 1679 595 to 1       595/595
(100 %)
8 diff
(98.7 %id)
BE906627 epithelioid carcinoma, Pancreas .c 1091 to 1694 1 to 606       606/606
(100 %)
3 diff
(99.6 %id)
AL564925 adult brain, brain .c 1092 to 2176 1071 to 2       1070/1091
(98 %)
24 diff
(97.9 %id)
CB215925 normal endometrium, late proliferativephase, cycle day 13, uterus .c 1098 to 1716 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM149290 leukopheresis .c 1100 to 1679 580 to 1       580/582
(99 %)
2 diff
(99.7 %id)
BF341097 brain, glioblastoma with EGFR amplification .c 1106 to 1925 1 to 819       819/845
(96 %)
27 diff
(96.9 %id)
BG335526 choriocarcinoma, placenta .c 1106 to 1885 1 to 775       775/959
(80 %)
21 diff
(97.9 %id)
BF338060 brain, glioblastoma with EGFR amplification .c 1115 to 1896 1 to 777       777/886
(87 %)
26 diff
(97.1 %id)
BE245785 leukopheresis .c 1116 to 1679 564 to 1       564/564
(100 %)
6 diff
(99.0 %id)
BM152963 leukopheresis .c 1124 to 1679 556 to 1       556/556
(100 %)
7 diff
(98.8 %id)
BE408001 choriocarcinoma, placenta .c 1126 to 1851 1 to 716       716/767
(93 %)
13 diff
(98.4 %id)
BE280886 choriocarcinoma, placenta .c 1127 to 1713 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
BM705118 eye, RPE and Choroid .c 1130 to 1710 1 to 582       582/584
(99 %)
5 diff
(99.2 %id)
BM709125 eye, RPE and Choroid .c 1130 to 1669 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BF685563 leiomyosarcoma cell line, uterus .c 1132 to 1892 1 to 761       761/846
(89 %)
22 diff
(97.4 %id)
BM151925 leukopheresis .c 1146 to 1679 534 to 1       534/536
(99 %)
7 diff
(98.7 %id)
BM194157 leukopheresis .c 1150 to 1679 530 to 1       530/531
(99 %)
9 diff
(98.4 %id)
BM503789 Pancreas, Purified pancreatic islet .c 1156 to 1561 1 to 406       406/406
(100 %)
0 diff
(100 %id)
BF347842 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1156 to 1926 6 to 775       770/883
(87 %)
28 diff
(96.9 %id)
BM014777 breast, mammary adenocarcinoma, cell line .c 1156 to 2011 27 to 880       854/881
(96 %)
31 diff
(96.5 %id)
TI_59392835   .c 1156 to 2011 73 to 926       854/882
(96 %)
31 diff
(96.5 %id)
BE562485 endometrium, adenocarcinoma cell line, uterus .c 1166 to 2037 1 to 863       863/951
(90 %)
67 diff
(93.0 %id)
BQ427497 leiomyosarcoma, uterus .c 1166 to 1989 1 to 832       832/871
(95 %)
24 diff
(97.3 %id)
BQ721927 sympathetic trunk .c 1169 to 1930 10 to 782       773/824
(93 %)
30 diff
(96.4 %id)
BQ944117 carcinoma, cell line, Prostate .c 1171 to 2038 1 to 870       870/925
(94 %)
15 diff
(98.4 %id)
CN421608 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1182 to 1700 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BQ953885 epidermoid carcinoma, cell line, lung .c 1190 to 2143 1 to 961       961/974
(98 %)
31 diff
(96.9 %id)
BG752649 eye, normal pigmented retinal epithelium .c 1194 to 1962 12 to 779       768/782
(98 %)
9 diff
(98.9 %id)
AL534941 brain, fetal brain .c 1314 to 2149 834 to 1       671/834
(80 %)
15 diff
(98.3 %id)
BG775335 carcinoma, cell line, Prostate .c 1357 to 2159 806 to 1   fully sequenced,   806/806
(100 %)
3 diff
(99.7 %id)
BM680407 eye, fetal eye .c 1433 to 2126 713 to 19   AAA   695/695
(100 %)
2 diff
(99.8 %id)
BI085705 astrocytoma grade IV, cell line, brain .c 1526 to 2124 623 to 1       623/656
(94 %)
32 diff
(95.2 %id)
AU144317 whole embryo, mainly head .c 1664 to 2206 550 to 1       550/552
(99 %)
15 diff
(97.3 %id)
H24008 whole brain .c 1717 to 2126 436 to 16   AAA   421/421
(100 %)
13 diff
(97.0 %id)
CB068923 Pancreas, Purified pancreatic islet .c 1796 to 2125 330 to 1       330/330
(100 %)
0 diff
(100 %id)
T08158   .c 1820 to 2206 387 to 1       387/390
(99 %)
5 diff
(98.8 %id)
BU731160 eye, RPE and Choroid .c 1869 to 2204 354 to 19   AAA   336/336
(100 %)
1 diff
(99.8 %id)
F09039 brain, total brain .c 1885 to 2204 320 to 1       320/320
(100 %)
0 diff
(100 %id)
DC353271 brain .d 1 to 511 1 to 511   tiling clone,   511/511
(100 %)
0 diff
(100 %id)
DB461945 testis .d 28 to 511 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BM461974 leiomyosarcoma, uterus .d 32 to 777 1 to 747       747/943
(79 %)
11 diff
(98.9 %id)
TI_44349138   .d 45 to 721 74 to 750       677/750
(90 %)
6 diff
(99.2 %id)
BI560901 testis .d 50 to 721 1 to 672       672/672
(100 %)
4 diff
(99.5 %id)
AU118204 whole embryo, mainly head .d 73 to 814 53 to 793   capped   741/764
(96 %)
18 diff
(97.7 %id)
DC360720   .d 74 to 637 7 to 571       565/571
(98 %)
8 diff
(98.6 %id)
DB446231 testis .d 82 to 522 1 to 441       443/441
(100 %)
15 diff
(96.6 %id)
DC421295 uterus .d 83 to 656 1 to 574       574/574
(100 %)
0 diff
(100 %id)
DC363611   .d 86 to 648 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
DC402586 testis .d 86 to 633 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DC402992 testis .d 86 to 666 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC325320 brain .d 92 to 679 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BI460648 testis .d 93 to 764 1 to 672       672/672
(100 %)
5 diff
(99.3 %id)
DC374701 brain .d 94 to 365 1 to 272       272/272
(100 %)
1 diff
(99.7 %id)
BI824038 pooled brain, lung, testis .d 97 to 557 1 to 463       463/463
(100 %)
5 diff
(99.0 %id)
TI_57200915   .d 97 to 557 59 to 521       463/521
(88 %)
9 diff
(98.3 %id)
DC340719 thalamus .d 98 to 668 1 to 571       571/574
(99 %)
2 diff
(99.7 %id)
DB473334 hippocampus .d 98 to 579 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
DC390742 Spleen .d 98 to 649 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
DC398123 testis .d 98 to 657 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
DC420896 uterus .d 98 to 661 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
DC422909 uterus .d 98 to 636 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
CR614826 neuroblastoma .d 99 to 2169 1 to 2071 exact tiling clone,   2071/2071
(100 %)
0 diff
(100 %id)
AL518855 brain, neuroblastoma, neuroblastoma cells .d 99 to 1108 1 to 998   fully sequenced,   998/998
(100 %)
13 diff
(98.7 %id)
BX387236 Placenta Cot 25-normalized .d 99 to 920 1 to 810       810/810
(100 %)
23 diff
(97.2 %id)
CD243670 testis .d 100 to 861 19 to 776       758/833
(90 %)
9 diff
(99.0 %id)
DB460336 testis .d 101 to 558 1 to 458       458/458
(100 %)
2 diff
(99.6 %id)
BI085207 astrocytoma grade IV, cell line, brain .d 101 to 940 1 to 857       854/942
(90 %)
39 diff
(95.9 %id)
BG471302 eye, retinoblastoma .d 104 to 779 1 to 705       703/1088
(64 %)
54 diff
(95.1 %id)
BG471712 eye, retinoblastoma .d 104 to 819 1 to 717       717/717
(100 %)
4 diff
(99.5 %id)
BG479424 choriocarcinoma, placenta .d 104 to 936 1 to 857       829/945
(87 %)
56 diff
(94.1 %id)
BI832326 brain, medulla .d 104 to 887 26 to 817       792/818
(96 %)
22 diff
(97.4 %id)
TI_57170877   .d 104 to 887 26 to 817       792/818
(96 %)
22 diff
(97.4 %id)
DC392957 breast, tumor tissue .d 104 to 644 1 to 541       541/541
(100 %)
0 diff
(100 %id)
TI_57166914   .d 105 to 668 30 to 603       574/871
(65 %)
12 diff
(98.7 %id)
BC091505 testis .d 106 to 2271 1 to 2166 exact AAA   2166/2166
(100 %)
1 diff
(100.0 %id)
AL530238 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 106 to 936 1 to 835       835/1007
(82 %)
34 diff
(96.7 %id)
DC354207 brain .d 108 to 656 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BU528934 epidermoid carcinoma, cell line, lung .d 108 to 837 1 to 735       735/913
(80 %)
17 diff
(98.2 %id)
DC367265   .d 108 to 637 1 to 530       530/530
(100 %)
4 diff
(99.3 %id)
DC368794   .d 108 to 641 1 to 534       534/534
(100 %)
4 diff
(99.3 %id)
DC395266 testis .d 108 to 662 1 to 555       555/555
(100 %)
0 diff
(100 %id)
DC413842 trachea .d 108 to 463 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
DC419702 uterus .d 108 to 688 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DC427877   .d 109 to 702 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BG424298 Kidney, renal cell adenocarcinoma .d 109 to 838 1 to 722       722/840
(85 %)
20 diff
(97.7 %id)
BG425688 Kidney, renal cell adenocarcinoma .d 109 to 836 1 to 737       734/874
(83 %)
13 diff
(98.6 %id)
DC376265 brain .d 109 to 656 1 to 548       548/549
(99 %)
2 diff
(99.7 %id)
DC385113   .d 109 to 678 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
DC295218 synovial membrane tissue from rheumatioidarthritis .d 109 to 664 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DC408029 thymus .d 109 to 597 1 to 489       489/489
(100 %)
1 diff
(99.8 %id)
DC313094 amygdala .d 110 to 686 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
BP249886 hippocampus .d 110 to 712 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
DC359777   .d 110 to 656 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
DC387163   .d 110 to 657 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
DC392351 stomach .d 110 to 679 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
DC295498 synovial membrane tissue from rheumatioidarthritis .d 110 to 656 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
DB483059 hippocampus .d 111 to 601 1 to 491       491/491
(100 %)
1 diff
(99.8 %id)
BI833823 pooled pancreas and spleen .d 112 to 668 1 to 567       567/835
(67 %)
10 diff
(98.9 %id)
BP341415 stomach mucosa .d 112 to 694 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB133863 thymus .d 112 to 656 2 to 552   capped   551/551
(100 %)
8 diff
(98.6 %id)
CN421604 embryonic stem cells, cell lines H1, H7, andH9 .d 115 to 716 1 to 603       603/603
(100 %)
3 diff
(99.6 %id)
AL554152 placenta, Placenta Cot 25-normalized .d 115 to 1243 1 to 1109       1109/1109
(100 %)
31 diff
(97.3 %id)
CD171748 testis .d 115 to 936 1 to 834       834/851
(98 %)
26 diff
(97.0 %id)
TI_57166954   .d 115 to 710 23 to 636       614/636
(96 %)
25 diff
(96.1 %id)
CN421599 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 116 to 830 12 to 726       715/726
(98 %)
6 diff
(99.2 %id)
BM450167 melanotic melanoma, skin .d 117 to 891 5 to 786       782/1092
(71 %)
26 diff
(97.7 %id)
AL528217 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 118 to 1121 1 to 1006       1006/1006
(100 %)
26 diff
(97.5 %id)
DB463982.
matches multiple genes
hippocampus .d 118 to 590 1 to 473     also hits gene FARP2 473/473
(100 %)
1 diff
(99.8 %id)
BI559691 testis .d 118 to 765 1 to 648       648/648
(100 %)
5 diff
(99.3 %id)
DC392025 Spleen .d 118 to 690 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
AU077121   .d 118 to 400 1 to 283       283/283
(100 %)
9 diff
(96.9 %id)
DC408430 thymus .d 119 to 673 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DC418156 trachea .d 119 to 678 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AU127309   .d 120 to 668 2 to 548   capped   547/556
(98 %)
7 diff
(98.8 %id)
DC420207 uterus .d 121 to 672 1 to 552       552/552
(100 %)
0 diff
(100 %id)
DC319352 brain .d 122 to 656 1 to 535       535/535
(100 %)
3 diff
(99.5 %id)
DC320017 brain .d 122 to 702 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC351711 brain .d 122 to 681 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
BE267793 Burkitt lymphoma, lymph .d 122 to 764 1 to 641       641/641
(100 %)
3 diff
(99.6 %id)
TI_44347951   .d 122 to 765 96 to 739       644/739
(87 %)
7 diff
(99.1 %id)
DC367719   .d 122 to 688 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
DC404732 thymus .d 122 to 674 1 to 553       553/553
(100 %)
0 diff
(100 %id)
DC405703 thymus .d 122 to 691 1 to 576       576/576
(100 %)
6 diff
(99.0 %id)
BI833862 pooled pancreas and spleen .d 123 to 710 1 to 606       606/606
(100 %)
23 diff
(96.3 %id)
BX333006 Neuroblastoma Cot 25-normalized .d 124 to 1068 17 to 952       936/986
(94 %)
37 diff
(96.3 %id)
BI911284 leukocyte .d 124 to 936 35 to 861       824/1036
(79 %)
33 diff
(96.9 %id)
TI_57231415   .d 124 to 936 35 to 861       824/1036
(79 %)
33 diff
(96.9 %id)
BP265802 thyroid .d 124 to 705 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BX374852 Neuroblastoma Cot 25-normalized .d 126 to 1122 18 to 999       982/999
(98 %)
25 diff
(97.5 %id)
BM453128 leiomyosarcoma, uterus .d 126 to 934 1 to 811       811/1045
(77 %)
4 diff
(99.7 %id)
BM926590 pooled lung and spleen .d 126 to 1124 13 to 1014       1002/1083
(92 %)
29 diff
(97.4 %id)
BQ707894 Spleen .d 126 to 887 1 to 770       767/981
(78 %)
23 diff
(97.7 %id)
BE886247 leiomyosarcoma, uterus .d 129 to 777 1 to 650       650/791
(82 %)
4 diff
(99.5 %id)
BF686732 leiomyosarcoma cell line, uterus .d 130 to 826 1 to 695       695/696
(99 %)
7 diff
(99.0 %id)
BI829673 brain, medulla .d 131 to 520 1 to 398       398/591
(67 %)
9 diff
(98.5 %id)
DC361866 Kidney .d 131 to 690 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC375335 brain .d 131 to 583 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
DC402346 testis .d 131 to 656 1 to 526       526/526
(100 %)
0 diff
(100 %id)
DC407047 thymus .d 131 to 694 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DC422038 uterus .d 131 to 677 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
DC352315 brain .d 134 to 715 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DC386935   .d 134 to 701 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC389412 Spleen .d 134 to 740 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
DC411237 kidney, tumor tissue .d 134 to 728 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BG772326 testis .d 135 to 887 1 to 752       752/761
(98 %)
8 diff
(99.0 %id)
BQ711662 Spleen .d 135 to 1010 1 to 878       878/953
(92 %)
21 diff
(97.8 %id)
BI193392 epithelioid carcinoma cell line, Pancreas .d 136 to 815 1 to 681       681/681
(100 %)
4 diff
(99.5 %id)
DC305968 cerebellum .d 137 to 656 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
DC329023 corpus callosum .d 137 to 680 1 to 544       544/544
(100 %)
0 diff
(100 %id)
DC372938   .d 137 to 729 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
DC387387   .d 137 to 683 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
DC299806   .d 140 to 692 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
DC316267 amygdala .d 140 to 631 1 to 492       492/492
(100 %)
0 diff
(100 %id)
DC318986 brain .d 140 to 656 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DC362973 Liver .d 140 to 726 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
DC365165   .d 140 to 649 1 to 510       510/510
(100 %)
0 diff
(100 %id)
DC365645   .d 140 to 686 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC367041   .d 140 to 664 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
DC371859   .d 140 to 705 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC375850 brain .d 140 to 719 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DC384242 Prostate .d 140 to 457 1 to 318       318/318
(100 %)
0 diff
(100 %id)
AU129432   .d 141 to 840 2 to 701   capped   700/706
(99 %)
9 diff
(98.8 %id)
DC328046 corpus callosum .d 142 to 712 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC354616 lung .d 142 to 725 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DC365841   .d 142 to 561 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
BX444914 brain, fetal brain .d 143 to 1153 1 to 996       996/999
(99 %)
28 diff
(97.2 %id)
BI919065 brain .d 144 to 885 1 to 756       753/756
(99 %)
31 diff
(95.9 %id)
TI_57241877   .d 144 to 885 1 to 756       753/756
(99 %)
31 diff
(95.9 %id)
BI911368 leukocyte .d 146 to 917 1 to 807   AAA   804/1231
(65 %)
59 diff
(95.3 %id)
TI_57231651   .d 146 to 917 1 to 807   AAA   804/1231
(65 %)
59 diff
(95.3 %id)
BF686270 leiomyosarcoma cell line, uterus .d 151 to 924 1 to 774       774/1016
(76 %)
32 diff
(96.9 %id)
BF685832 leiomyosarcoma cell line, uterus .d 151 to 922 1 to 782       782/1058
(73 %)
24 diff
(97.8 %id)
BF972935 leiomyosarcoma cell line, uterus .d 151 to 896 1 to 751       748/751
(99 %)
14 diff
(98.2 %id)
BG338444 leiomyosarcoma cell line, uterus .d 151 to 936 1 to 791       791/1080
(73 %)
23 diff
(97.9 %id)
BG339068 leiomyosarcoma cell line, uterus .d 151 to 937 1 to 787       787/976
(80 %)
12 diff
(98.8 %id)
BQ070436 brain, neuroblastoma, cell line .d 153 to 840 1 to 689       689/1048
(65 %)
7 diff
(99.4 %id)
BU528171 epidermoid carcinoma, cell line, lung .d 154 to 1023 33 to 920       885/944
(93 %)
27 diff
(97.2 %id)
BU177668 adenocarcinoma, Pancreas .d 162 to 615 1 to 461       461/868
(53 %)
9 diff
(99.0 %id)
BQ923352 epidermoid carcinoma, cell line, lung .d 162 to 944 1 to 793       790/855
(92 %)
14 diff
(98.4 %id)
BJ990511 hepatoblastoma .d 178 to 760 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC366294   .d 180 to 751 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
TI_154137717   .d 188 to 779 75 to 669       595/601
(99 %)
19 diff
(96.9 %id)
CN421609 embryonic stem cells, cell lines H1, H7, andH9 .d 195 to 889 13 to 708       696/708
(98 %)
7 diff
(99.1 %id)
DB447274 testis .d 198 to 611 1 to 413       413/422
(97 %)
6 diff
(98.6 %id)
BG748122 eye, normal pigmented retinal epithelium .d 239 to 1122 1 to 880       880/884
(99 %)
26 diff
(97.1 %id)
BM787832 stomach .d 247 to 847 1 to 601       601/601
(100 %)
0 diff
(100 %id)
CB142447 Liver .d 249 to 786 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
DA013055 adrenal gland .d 279 to 842 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
T31794 colon, embryo .d 285 to 585 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
BM827594 stomach .d 306 to 475 1 to 169       169/169
(100 %)
12 diff
(92.9 %id)
AL045035 testis .d 309 to 647 1 to 339       339/339
(100 %)
0 diff
(100 %id)
TI_1948128020   .d 350 to 777 120 to 547       428/1127
(37 %)
18 diff
(98.5 %id)
BF949290 nervous_normal .d 357 to 731 372 to 1       372/372
(100 %)
10 diff
(97.4 %id)
AL046738 testis .d 357 to 777 1 to 420       420/420
(100 %)
0 diff
(100 %id)
AL518854 brain, neuroblastoma, neuroblastoma cells .d 1078 to 2169 1088 to 1   fully sequenced,   1088/1088
(100 %)
17 diff
(98.5 %id)
AL576952 placenta, Placenta Cot 25-normalized .d 1262 to 2219 977 to 26       952/1059
(89 %)
20 diff
(98.2 %id)
AL563089 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1281 to 2233 947 to 1       947/960
(98 %)
27 diff
(97.2 %id)
BI085853 astrocytoma grade IV, cell line, brain .d 1613 to 2222 625 to 5       621/766
(81 %)
0 diff
(100 %id)
AL563680 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 1713 to 2253 549 to 1       549/695
(78 %)
13 diff
(98.2 %id)
BJ990512 hepatoblastoma .d 1713 to 2252 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
AU151548   .d 1729 to 2271 537 to 1   tiling clone,   537/578
(92 %)
7 diff
(98.8 %id)
AU144831 whole embryo, mainly head .d 1796 to 2271 475 to 1       475/477
(99 %)
3 diff
(99.4 %id)
DB364146   .d 1863 to 2170 312 to 1       312/312
(100 %)
9 diff
(97.2 %id)
DC409688 thymus .e 1 to 599 3 to 601   tiling clone,   601/601
(100 %)
2 diff
(99.7 %id)
TI_57199325   .e 2 to 543 57 to 596       540/596
(90 %)
7 diff
(98.9 %id)
BI821634 pooled brain, lung, testis .e 8 to 543 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
AK301214 Spleen .e 12 to 1558 1 to 1547 exact tiling clone,   1547/1547
(100 %)
2 diff
(99.9 %id)
DC365941   .e 12 to 562 1 to 552       552/552
(100 %)
2 diff
(99.7 %id)
DC391139 Spleen .e 12 to 569 1 to 559       559/562
(99 %)
4 diff
(99.3 %id)
DC398552 testis .e 16 to 563 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
DC399435 testis .e 39 to 508 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
AA173101   .e 40 to 451 1 to 416       413/416
(99 %)
27 diff
(93.6 %id)
DC328716 corpus callosum .e 42 to 604 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BU931954 ovary, teratocarcinoma, cell line .e 48 to 788 1 to 748       748/952
(78 %)
25 diff
(97.4 %id)
BF309243 muscle, rhabdomyosarcoma .e 94 to 739 1 to 647       647/654
(98 %)
3 diff
(99.6 %id)
BQ894611 Spleen .e 250 to 1119 1 to 887       887/956
(92 %)
30 diff
(96.9 %id)
BE263823 lung, small cell carcinoma .e 430 to 1041 1 to 615       615/615
(100 %)
4 diff
(99.4 %id)
AA173271   .e 1530 to 2126 604 to 3   tiling clone,   602/604
(99 %)
0 diff
(100 %id)
AK291808 Prostate .f 1 to 1643 1 to 1643 exact tiling clone,   1643/1643
(100 %)
0 diff
(100 %id)
DA870900 Prostate .f 2 to 561 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AK092161   .g 1 to 1904 1 to 1904 E168D tiling clone, available from FLJ,   1904/1904
(100 %)
2 diff
(99.9 %id)
DA691364   .g 2 to 568 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB323143   .g 1473 to 1904 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
AK315966 amygdala .h 1 to 1535 2 to 1536   tiling clone,   1536/1536
(100 %)
0 diff
(100 %id)
DA169351 amygdala .h 1 to 579 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA692904   .h 12 to 581 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB255994 uterus .h 12 to 563 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA171284 amygdala .i 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
AK303719 kidney, tumor tissue .i 185 to 2160 1 to 1976 S234G tiling clone,   1976/1976
(100 %)
1 diff
(100.0 %id)
DB174974 kidney, tumor tissue .i 186 to 747 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB454127 testis .i 390 to 869 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
DB446965 testis .i 391 to 828 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
CX786137 human embryonic stem cells .i 404 to 1204 1 to 800       800/800
(100 %)
2 diff
(99.8 %id)
BG960225 colon .i 505 to 881 16 to 390       378/402
(94 %)
14 diff
(96.6 %id)
BE296440 muscle, rhabdomyosarcoma .i 506 to 1165 1 to 656       656/703
(93 %)
11 diff
(98.5 %id)
BE269257 Burkitt lymphoma, lymph .i 508 to 1188 3 to 673       673/729
(92 %)
8 diff
(99.0 %id)
BE259222 eye, retinoblastoma .i 517 to 941 29 to 452       424/452
(93 %)
6 diff
(98.7 %id)
BI462009 testis .i 518 to 1334 1 to 814       814/817
(99 %)
16 diff
(98.1 %id)
BE241543 leukopheresis .i 518 to 816 1 to 299       299/299
(100 %)
1 diff
(99.7 %id)
BE242504 leukopheresis .i 518 to 816 1 to 299       299/299
(100 %)
2 diff
(99.4 %id)
BE242512 leukopheresis .i 518 to 874 1 to 358       358/358
(100 %)
4 diff
(98.9 %id)
BE241928 leukopheresis .i 518 to 656 1 to 139       139/139
(100 %)
5 diff
(96.5 %id)
BE243413 leukopheresis .i 518 to 875 1 to 358       358/358
(100 %)
1 diff
(99.8 %id)
BE243798 leukopheresis .i 518 to 958 1 to 441       441/441
(100 %)
0 diff
(100 %id)
BE243805 leukopheresis .i 518 to 1002 1 to 483       483/492
(98 %)
7 diff
(98.6 %id)
BM153260 leukopheresis .i 518 to 883 1 to 364       364/365
(99 %)
11 diff
(97.0 %id)
BE244844 leukopheresis .i 518 to 720 1 to 202       202/202
(100 %)
3 diff
(98.6 %id)
BM151303 leukopheresis .i 518 to 837 1 to 319       319/319
(100 %)
2 diff
(99.4 %id)
DB447357 testis .i 525 to 961 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
BG471600 eye, retinoblastoma .i 527 to 1248 1 to 721       721/728
(99 %)
6 diff
(99.2 %id)
BQ927300 large cell carcinoma, lung .i 527 to 1400 1 to 877       877/933
(93 %)
17 diff
(98.2 %id)
BQ682116 melanotic melanoma, cell line, skin .i 539 to 1248 1 to 715       715/869
(82 %)
6 diff
(99.4 %id)
BQ677868 melanotic melanoma, cell line, skin .i 539 to 1390 1 to 847       847/936
(90 %)
22 diff
(97.7 %id)
BQ899148 melanotic melanoma, cell line, skin .i 539 to 1248 1 to 715       715/967
(73 %)
16 diff
(98.4 %id)
BM458355 lymph, lymphoma, cell line .i 540 to 1510 1 to 967       967/1106
(87 %)
22 diff
(98.1 %id)
BG747940 eye, normal pigmented retinal epithelium .i 548 to 1307 1 to 758       758/759
(99 %)
15 diff
(98.1 %id)
BG747563 eye, normal pigmented retinal epithelium .i 552 to 1125 1 to 585       585/690
(84 %)
16 diff
(97.7 %id)
BQ888007 eye, normal pigmented retinal epithelium .i 552 to 1381 1 to 834       834/834
(100 %)
4 diff
(99.6 %id)
BQ919437 large cell carcinoma, lung .i 555 to 1462 13 to 934       922/937
(98 %)
19 diff
(98.0 %id)
BQ925483 epidermoid carcinoma, cell line, lung .i 560 to 1394 1 to 835       835/903
(92 %)
8 diff
(99.2 %id)
BI047359 prostate_tumor .i 567 to 966 25 to 422       398/422
(94 %)
7 diff
(98.4 %id)
BI047360 prostate_tumor .i 570 to 883 18 to 336       319/336
(94 %)
7 diff
(98.0 %id)
BG763832 melanotic melanoma, high MDR (cell line), skin .i 578 to 1400 1 to 828       828/839
(98 %)
18 diff
(97.9 %id)
BE910650 epithelioid carcinoma, Pancreas .i 591 to 1203 1 to 622       622/622
(100 %)
19 diff
(97.0 %id)
DB104610 thymus .i 595 to 1144 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BI047357 prostate_tumor .i 597 to 944 1 to 355       321/355
(90 %)
31 diff
(91.3 %id)
BE735132 choriocarcinoma, placenta .i 598 to 1359 58 to 818       761/818
(93 %)
7 diff
(99.2 %id)
BG423524 Kidney, renal cell adenocarcinoma .i 614 to 1334 1 to 719       719/760
(94 %)
21 diff
(97.3 %id)
CF144994 CNCAP(3)T-225 cell line, Prostate .i 615 to 1046 1 to 432       432/432
(100 %)
7 diff
(98.4 %id)
BP375384 uterus .i 618 to 1172 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
BM799771 eye, retinoblastoma .i 620 to 1579 1 to 962       962/1087
(88 %)
13 diff
(98.9 %id)
BU146088 brain, neuroblastoma, cell line .i 622 to 1498 26 to 905       880/985
(89 %)
27 diff
(97.3 %id)
TI_154177151   .i 622 to 1162 80 to 620       541/541
(100 %)
3 diff
(99.5 %id)
BE315240 adenocarcinoma cell line, ovary .i 631 to 1443 1 to 812       812/812
(100 %)
2 diff
(99.8 %id)
CN421589 embryonic stem cells, cell lines H1, H7, andH9 .i 632 to 1308 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
CD622526   .i 636 to 1151 8 to 523       516/541
(95 %)
1 diff
(99.9 %id)
CD622527   .i 636 to 1151 529 to 15       515/536
(96 %)
0 diff
(100 %id)
BG959558 colon .i 647 to 1065 448 to 36       413/448
(92 %)
2 diff
(99.6 %id)
BE312120 brain, neuroblastoma .i 647 to 1308 1 to 659       661/659
(100 %)
16 diff
(97.6 %id)
BQ941917 epidermoid carcinoma, cell line, lung .i 651 to 1514 1 to 867       867/886
(97 %)
11 diff
(98.8 %id)
BP249772 hippocampus .i 655 to 1242 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
BQ347953 head_neck .i 660 to 1056 474 to 78       397/474
(83 %)
2 diff
(99.6 %id)
BQ348486 head_neck .i 660 to 1056 474 to 78       397/474
(83 %)
2 diff
(99.6 %id)
BQ051055 leiomyosarcoma, uterus .i 662 to 1445 1 to 787       787/1028
(76 %)
12 diff
(98.9 %id)
BE280387 choriocarcinoma, placenta .i 664 to 1346 1 to 675       675/679
(99 %)
12 diff
(98.3 %id)
BM721447 eye, fetal eye .i 674 to 1156 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
AA099502 Pancreas .i 676 to 1063 1 to 391       391/397
(98 %)
7 diff
(98.3 %id)
BG958617 colon .i 693 to 1065 391 to 27       362/391
(92 %)
0 diff
(100 %id)
BG471515 eye, retinoblastoma .i 696 to 1327 1 to 633       633/633
(100 %)
6 diff
(99.1 %id)
BE259512 eye, retinoblastoma .i 697 to 1287 11 to 601       591/601
(98 %)
6 diff
(99.1 %id)
BU849530 ovary, teratocarcinoma, cell line .i 701 to 1514 1 to 816       816/848
(96 %)
11 diff
(98.8 %id)
BU850160 ovary, teratocarcinoma, cell line .i 701 to 1514 1 to 824   AAA   824/907
(90 %)
19 diff
(98.0 %id)
CB123587 Liver .i 703 to 1257 1 to 555       555/555
(100 %)
0 diff
(100 %id)
EC569004 Prostate .i 706 to 806 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BG286898 bladder, transitional cell papilloma, cell line .i 710 to 1391 1 to 683       683/987
(69 %)
20 diff
(98.0 %id)
BE255807 eye, retinoblastoma .i 716 to 1387 1 to 661       661/728
(90 %)
17 diff
(97.7 %id)
BE258241 eye, retinoblastoma .i 716 to 1369 1 to 657       657/657
(100 %)
10 diff
(98.5 %id)
BE258303 eye, retinoblastoma .i 716 to 1346 1 to 630       630/630
(100 %)
6 diff
(99.1 %id)
BE255453 eye, retinoblastoma .i 716 to 1224 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BE253308 eye, retinoblastoma .i 716 to 1306 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
BG958952 colon .i 725 to 1094 453 to 86       368/454
(81 %)
3 diff
(99.4 %id)
TI_1948078131   .i 737 to 1757 1141 to 126       1016/1279
(79 %)
26 diff
(98.0 %id)
BP305546   .i 744 to 1323 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM854962 stomach .i 757 to 1255 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BQ217473 melanotic melanoma, skin .i 760 to 1514 1 to 758       758/829
(91 %)
6 diff
(99.3 %id)
CX786271 human embryonic stem cells .i 781 to 1463 1 to 682       682/682
(100 %)
1 diff
(99.9 %id)
BE781149 eye, retinoblastoma .i 784 to 1414 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
TI_1948077816   .i 796 to 1757 1088 to 130       959/1256
(76 %)
12 diff
(99.1 %id)
TI_1948078459   .i 798 to 1757 1086 to 127       960/1276
(75 %)
21 diff
(98.4 %id)
BP333477 salivary gland .i 826 to 1407 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ669795 epidermoid carcinoma, cell line, salivary gland .i 834 to 1628 10 to 812       803/927
(86 %)
31 diff
(96.7 %id)
CV311438 head_neck .i 846 to 1290 446 to 2     Submitted on the opposite strand 445/446
(99 %)
0 diff
(100 %id)
CV569340 cornea, eye .i 847 to 1400 1 to 554       554/556
(99 %)
4 diff
(99.3 %id)
BQ960656 sciatic nerve .i 860 to 1679 1 to 825       825/918
(89 %)
11 diff
(98.9 %id)
BQ888378 epidermoid carcinoma, cell line, lung .i 861 to 1673 1 to 819       819/936
(87 %)
22 diff
(97.7 %id)
BQ922387 epidermoid carcinoma, cell line, lung .i 861 to 1768 1 to 917       915/961
(95 %)
16 diff
(98.4 %id)
CN421594 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 867 to 1350 1 to 484       484/484
(100 %)
0 diff
(100 %id)
DB046644 testis .i 867 to 1426 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BG911067 anaplastic oligodendroglioma with 1p/19qloss, brain .i 881 to 1578 15 to 711       697/732
(95 %)
8 diff
(99.0 %id)
BQ227725 epithelioid carcinoma, Pancreas .i 892 to 1581 1 to 701       701/914
(76 %)
16 diff
(98.3 %id)
BU856463 ovary, teratocarcinoma, cell line .i 894 to 1706 1 to 818       818/919
(89 %)
21 diff
(97.8 %id)
CX754577 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 896 to 1588 1 to 692     Submitted on the opposite strand 692/842
(82 %)
8 diff
(99.1 %id)
CB154523 brain .i 900 to 1408 1 to 509       509/509
(100 %)
0 diff
(100 %id)
CX871758 embryonic stem .i 901 to 1583 1 to 683       683/683
(100 %)
0 diff
(100 %id)
CV812690 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 902 to 1706 1 to 806       806/871
(92 %)
12 diff
(98.7 %id)
CN421595 embryonic stem cells, DMSO-treated H9 cellline .i 913 to 1575 1 to 662       662/662
(100 %)
1 diff
(99.9 %id)
BI819285 pooled brain, lung, testis .i 919 to 1752 1 to 834       834/839
(99 %)
11 diff
(98.7 %id)
TI_57200145   .i 919 to 1752 67 to 900       834/905
(92 %)
15 diff
(98.4 %id)
TI_1948128353   .i 924 to 1757 960 to 127       834/1089
(76 %)
23 diff
(97.9 %id)
TI_1948129024   .i 925 to 1757 961 to 125       837/1101
(76 %)
21 diff
(98.1 %id)
BF975687 B-cells, primary B-cells from tonsils (cell line) .i 927 to 1603 1 to 673       673/673
(100 %)
6 diff
(99.2 %id)
TI_1948078801   .i 930 to 1757 972 to 124       849/1394
(60 %)
30 diff
(97.9 %id)
BG762483 melanotic melanoma, high MDR (cell line), skin .i 936 to 1719 1 to 785       785/815
(96 %)
13 diff
(98.5 %id)
BG765455 melanotic melanoma, high MDR (cell line), skin .i 936 to 1794 1 to 856       856/882
(97 %)
14 diff
(98.5 %id)
BG768677 melanotic melanoma, high MDR (cell line), skin .i 936 to 1671 1 to 736       736/736
(100 %)
7 diff
(99.1 %id)
CB123223 Liver .i 974 to 1350 1 to 377       377/377
(100 %)
0 diff
(100 %id)
BQ230668 epithelioid carcinoma, Pancreas .i 994 to 1862 1 to 877       877/880
(99 %)
16 diff
(98.2 %id)
BU527988 epidermoid carcinoma, cell line, lung .i 996 to 1783 1 to 792       792/908
(87 %)
15 diff
(98.4 %id)
BU528544 epidermoid carcinoma, cell line, lung .i 996 to 1898 1 to 911       911/914
(99 %)
15 diff
(98.4 %id)
BU501181 eye, normal pigmented retinal epithelium .i 1000 to 1827 1 to 836       836/844
(99 %)
16 diff
(98.2 %id)
CX868967 embryonic stem .i 1008 to 1791 1 to 784       784/784
(100 %)
0 diff
(100 %id)
BG397955 B-cells, primary B-cells from tonsils (cell line) .i 1027 to 1720 1 to 693       693/810
(85 %)
9 diff
(98.9 %id)
BG686499 B-cells, primary B-cells from tonsils (cell line) .i 1027 to 1891 1 to 863       863/864
(99 %)
13 diff
(98.5 %id)
BG758545 B-cells, primary B-cells from tonsils (cell line) .i 1027 to 1869 1 to 842       842/842
(100 %)
11 diff
(98.7 %id)
BG756217 B-cells, primary B-cells from tonsils (cell line) .i 1027 to 1927 1 to 900       898/990
(90 %)
25 diff
(97.5 %id)
BG250007 adenocarcinoma, cell line, Liver .i 1033 to 1754 1 to 713       713/948
(75 %)
11 diff
(98.9 %id)
CN421600 embryonic stem cells, DMSO-treated H9 cellline .i 1036 to 1654 1 to 621       621/621
(100 %)
5 diff
(99.2 %id)
AW998260 breast_normal .i 1038 to 1324 288 to 1     Submitted on the opposite strand 288/299
(96 %)
9 diff
(97.0 %id)
BG329983 eye, retinoblastoma .i 1046 to 1720 1 to 673       673/921
(73 %)
5 diff
(99.5 %id)
TI_57218382   .i 1047 to 1846 27 to 823   tiling clone,   797/823
(96 %)
11 diff
(98.7 %id)
AA410865 ovarian tumor, ovary .i 1051 to 1258 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BI754965 brain .i 1051 to 1846 1 to 793       793/793
(100 %)
5 diff
(99.4 %id)
DR763410 embryonic stem .i 1051 to 1757 1 to 707       707/707
(100 %)
0 diff
(100 %id)
AW998220 breast_normal .i 1058 to 1336 9 to 291       286/305
(93 %)
14 diff
(95.5 %id)
CN421605 embryonic stem cells, DMSO-treated H9 cellline .i 1063 to 1654 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BM848503 myeloma .i 1464 to 1695 1 to 232       232/232
(100 %)
0 diff
(100 %id)
FN095673 breast carcinoma .i 1609 to 1666 1 to 58       58/59
(98 %)
2 diff
(96.7 %id)
DB456293 testis .j -8 to 459 1 to 468       468/468
(100 %)
2 diff
(99.6 %id)
TI_57240477   .j 1 to 909 18 to 934       921/934
(98 %)
25 diff
(97.4 %id)
DA940843 Spleen .j 1 to 581 2 to 583   tiling clone, capped   582/582
(100 %)
2 diff
(99.7 %id)
DA727560   .j 7 to 572 10 to 585   capped   576/740
(77 %)
18 diff
(97.6 %id)
BI913438 brain .j 12 to 909 1 to 906       906/906
(100 %)
19 diff
(98.0 %id)
BM012003 brain, neuroblastoma, cell line .j 27 to 844 1 to 840       836/840
(99 %)
42 diff
(95.0 %id)
BU147390 dorsal root ganglia .j 27 to 732 24 to 731       708/970
(72 %)
27 diff
(97.3 %id)
BG703092 brain, hippocampus .j 28 to 693 1 to 664       664/664
(100 %)
9 diff
(98.7 %id)
BQ069198 brain, neuroblastoma, cell line .j 28 to 854 26 to 856       831/1078
(77 %)
22 diff
(98.0 %id)
TI_59381193   .j 28 to 844 102 to 940       835/839
(99 %)
41 diff
(95.2 %id)
BU146035 brain, neuroblastoma, cell line .j 30 to 940 1 to 910       910/913
(99 %)
9 diff
(99.1 %id)
BE281168 choriocarcinoma, placenta .j 32 to 733 31 to 730       700/775
(90 %)
15 diff
(98.1 %id)
AK297374 brain .j 34 to 1499 1 to 1466 I112V I306T tiling clone,   1466/1466
(100 %)
5 diff
(99.7 %id)
DB206887 trachea .j 34 to 566 2 to 534   capped   533/533
(100 %)
3 diff
(99.5 %id)
DA502316 brain .j 35 to 597 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA927637 small intestine .j 35 to 597 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DR760028 embryonic stem .j 48 to 828 1 to 781       781/781
(100 %)
5 diff
(99.4 %id)
BF317393 brain, neuroblastoma .j 49 to 733 1 to 680       680/775
(87 %)
17 diff
(97.9 %id)
BG749962 eye, normal pigmented retinal epithelium .j 49 to 917 1 to 854       854/943
(90 %)
12 diff
(98.8 %id)
BQ889516 brain, neuroblastoma, cell line .j 50 to 855 26 to 842       817/974
(83 %)
27 diff
(97.3 %id)
BM548644 brain, hippocampus .j 51 to 1027 13 to 996       984/1103
(89 %)
36 diff
(96.8 %id)
BE734683 choriocarcinoma, placenta .j 58 to 682 20 to 661       642/931
(68 %)
18 diff
(98.1 %id)
CX872833 embryonic stem .j 59 to 903 1 to 845   tiling clone,   845/845
(100 %)
0 diff
(100 %id)
BF308221 muscle, rhabdomyosarcoma .j 69 to 839 1 to 770       770/809
(95 %)
19 diff
(97.7 %id)
BF303741 muscle, rhabdomyosarcoma .j 78 to 778 1 to 692       692/923
(74 %)
15 diff
(98.4 %id)
BF308539 muscle, rhabdomyosarcoma .j 78 to 733 1 to 655       655/889
(73 %)
6 diff
(99.4 %id)
BF304509 muscle, rhabdomyosarcoma .j 78 to 595 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
BF304815 muscle, rhabdomyosarcoma .j 78 to 891 1 to 798       798/1095
(72 %)
32 diff
(97.1 %id)
BF306280 muscle, rhabdomyosarcoma .j 78 to 731 1 to 648       648/868
(74 %)
15 diff
(98.3 %id)
BF307555 muscle, rhabdomyosarcoma .j 78 to 731 1 to 654       652/824
(79 %)
10 diff
(98.8 %id)
BG824964 muscle, rhabdomyosarcoma .j 78 to 855 1 to 778       778/778
(100 %)
16 diff
(98.0 %id)
BG828942 muscle, rhabdomyosarcoma .j 78 to 825 1 to 749       749/749
(100 %)
1 diff
(99.9 %id)
BG828953 muscle, rhabdomyosarcoma .j 78 to 746 1 to 669       669/670
(99 %)
1 diff
(99.9 %id)
BF308593 muscle, rhabdomyosarcoma .j 79 to 776 1 to 693       693/946
(73 %)
11 diff
(98.9 %id)
BE298774 muscle, rhabdomyosarcoma .j 89 to 728 1 to 637       637/680
(93 %)
6 diff
(99.2 %id)
BG827784 muscle, rhabdomyosarcoma .j 154 to 848 1 to 713       713/994
(71 %)
28 diff
(97.2 %id)
CD671722 eye, Iris .j 615 to 1068 1 to 454       454/456
(99 %)
6 diff
(98.7 %id)
BI084426 epidermoid carcinoma, cell line, salivary gland .j 809 to 1684 1 to 880   fully sequenced,   880/880
(100 %)
19 diff
(97.9 %id)
BF570151 Kidney, renal carcinoma (ascites) .j 1175 to 2027 880 to 29       852/1097
(77 %)
23 diff
(98.0 %id)
CN421606 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 1181 to 1661 1 to 481       481/481
(100 %)
0 diff
(100 %id)
TI_154119658   .j 1182 to 2069 981 to 102       880/1069
(82 %)
31 diff
(97.2 %id)
BG403861 bladder, transitional cell papilloma, cell line .j 1198 to 1899 1 to 692       692/692
(100 %)
12 diff
(98.3 %id)
BE247614 leukopheresis .j 1204 to 1541 338 to 1       338/347
(97 %)
3 diff
(99.2 %id)
BM152238 leukopheresis .j 1214 to 1541 328 to 1       328/328
(100 %)
4 diff
(98.8 %id)
BG185592   .j 1234 to 2054 835 to 14     Submitted on the opposite strand 822/836
(98 %)
10 diff
(98.9 %id)
BG760011 B-cells, primary B-cells from tonsils (cell line) .j 1234 to 1991 1 to 750       750/956
(78 %)
22 diff
(97.7 %id)
BM152006 leukopheresis .j 1238 to 1541 304 to 1       304/319
(95 %)
6 diff
(98.2 %id)
BF237586 leiomyosarcoma cell line, uterus .j 1244 to 1874 1 to 631       631/967
(65 %)
11 diff
(98.9 %id)
BF237755 leiomyosarcoma cell line, uterus .j 1244 to 1959 1 to 719       719/1184
(60 %)
14 diff
(98.9 %id)
BF683870 leiomyosarcoma cell line, uterus .j 1246 to 1949 1 to 704       704/802
(87 %)
8 diff
(99.1 %id)
CR618964 fetal liver .j 1251 to 2016 1 to 766       766/766
(100 %)
0 diff
(100 %id)
BX406033 fetal liver, Liver .j 1251 to 1417 1 to 167   fully sequenced,   167/167
(100 %)
1 diff
(99.5 %id)
TI_159676538   .j 1272 to 1821 51 to 600       550/1032
(53 %)
56 diff
(94.6 %id)
CT003764 T-Lymphocytes .j 1273 to 1589 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BM142374 Islets of Langerhans, Pancreas .j 1278 to 1812 1 to 535       535/535
(100 %)
0 diff
(100 %id)
TI_149277645   .j 1281 to 1986 793 to 89   AAA   705/706
(99 %)
9 diff
(98.8 %id)
TI_151723802   .j 1302 to 1989 728 to 22   AAA   707/831
(85 %)
29 diff
(96.6 %id)
TI_149301729   .j 1306 to 2068 843 to 87   AAA   757/921
(82 %)
10 diff
(99.0 %id)
TI_149311423   .j 1306 to 2066 844 to 87   AAA   758/938
(80 %)
10 diff
(99.0 %id)
BU616527 Bone, Subchondral Bone .j 1315 to 2066 769 to 19   AAA   751/751
(100 %)
1 diff
(99.9 %id)
CN479216 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1316 to 2068 764 to 17   AAA   748/748
(100 %)
6 diff
(99.2 %id)
AA378181 synovial membrane .j 1318 to 1568 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BG752808 eye, normal pigmented retinal epithelium .j 1326 to 2004 1 to 677       677/677
(100 %)
8 diff
(98.9 %id)
BM977337 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1326 to 2066 758 to 19   AAA   740/740
(100 %)
5 diff
(99.4 %id)
DR159190 human embryonic stem cells differentiated toan early endodermal cell type .j 1329 to 2068 763 to 23   AAA Submitted on the opposite strand 741/741
(100 %)
3 diff
(99.6 %id)
BU677832 lung .j 1334 to 1986 673 to 19   AAA   655/655
(100 %)
3 diff
(99.6 %id)
AI915558 pooled .j 1337 to 1985 652 to 4       649/652
(99 %)
1 diff
(99.9 %id)
BE644622 pooled .j 1337 to 1988 652 to 1       652/652
(100 %)
9 diff
(98.7 %id)
BM980049 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1337 to 2068 745 to 17   AAA   729/729
(100 %)
5 diff
(99.4 %id)
BQ575092 Chondrosarcoma Grade II, Left Pelvis .j 1338 to 2070 747 to 19   AAA   729/729
(100 %)
5 diff
(99.4 %id)
BM472187 embryonal carcinoma, cell line, testis .j 1341 to 2068 1 to 727   tiling clone,   727/732
(99 %)
1 diff
(99.9 %id)
CB250694 Human Lung Epithelial cells, lung .j 1341 to 2074 748 to 19   AAA   730/730
(100 %)
4 diff
(99.5 %id)
AI085942 senescent fibroblast .j 1346 to 2069 729 to 5       725/731
(99 %)
3 diff
(99.6 %id)
TI_149285844   .j 1350 to 2066 799 to 86   AAA   714/714
(100 %)
9 diff
(98.8 %id)
BX406032 fetal liver, Liver .j 1356 to 2016 660 to 1   fully sequenced,   660/660
(100 %)
2 diff
(99.7 %id)
BQ010007 Chondrosarcoma, Left Pubic Bone .j 1361 to 2066 722 to 19   AAA   704/708
(99 %)
1 diff
(99.9 %id)
AA340181 brain .j 1362 to 1695 1 to 334       334/334
(100 %)
0 diff
(100 %id)
BU617752 Bone, Subchondral Bone .j 1374 to 2070 714 to 19   AAA   696/697
(99 %)
0 diff
(100 %id)
TI_149288842   .j 1382 to 2066 762 to 77   AAA   686/689
(99 %)
1 diff
(99.9 %id)
TI_149290088   .j 1382 to 2066 774 to 90   AAA   685/705
(97 %)
14 diff
(98.1 %id)
BM905791 leiomyosarcoma, uterus .j 1387 to 2066 1 to 679   AAA   679/679
(100 %)
1 diff
(99.9 %id)
BQ772950 Chondrosarcoma Cell line .j 1387 to 2066 698 to 19   AAA   680/684
(99 %)
0 diff
(100 %id)
BM971708 lung .j 1389 to 2068 694 to 17   AAA   678/684
(99 %)
4 diff
(99.5 %id)
BX112473 brain, glioblastoma (pooled) .j 1399 to 2059 1 to 660       660/660
(100 %)
2 diff
(99.7 %id)
BM970563 lung .j 1399 to 2066 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
TI_153958275   .j 1403 to 2068 79 to 766   AAA   688/688
(100 %)
33 diff
(95.3 %id)
BM708183 eye, RPE and Choroid .j 1405 to 1852 1 to 448       448/448
(100 %)
0 diff
(100 %id)
CA430197 cell lines, Chondrosarcoma .j 1409 to 2070 679 to 19   AAA   661/663
(99 %)
1 diff
(99.9 %id)
BU622512 cell lines, Chondrosarcoma .j 1411 to 2066 674 to 19   AAA   656/656
(100 %)
0 diff
(100 %id)
TI_154041319   .j 1419 to 2074 729 to 74   AAA   656/988
(66 %)
2 diff
(99.8 %id)
CB853215 Human Lung Epithelial cells, lung .j 1424 to 2066 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
BU618407 Cell Line, Chondrosarcoma .j 1424 to 2066 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
BF981500 duodenal adenocarcinoma, cell line, small intestine .j 1437 to 2106 15 to 684       670/684
(97 %)
6 diff
(99.2 %id)
BM806746 melanotic melanoma, skin .j 1446 to 2066 1 to 621   AAA   621/621
(100 %)
1 diff
(99.9 %id)
CD368690 Alveolar Macrophage, lung .j 1448 to 2065 637 to 19   AAA   619/623
(99 %)
5 diff
(99.2 %id)
AI761738 pooled .j 1457 to 1988 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
CA426228 Bone, Subchondral Bone .j 1473 to 2066 612 to 19   AAA   594/594
(100 %)
0 diff
(100 %id)
CN480115 Knee, Osteoarthritic Cartilage .j 1473 to 2074 620 to 19   AAA   602/602
(100 %)
0 diff
(100 %id)
CA414949 Chondrosarcoma Grade II, Left Pelvis .j 1473 to 2066 612 to 19   AAA   594/594
(100 %)
1 diff
(99.9 %id)
BM663920 eye, RPE and Choroid .j 1476 to 2068 611 to 19   AAA   593/593
(100 %)
1 diff
(99.9 %id)
R09758 liver and spleen .j 1477 to 1787 1 to 317       317/321
(98 %)
10 diff
(96.9 %id)
BQ680364 melanotic melanoma, cell line, skin .j 1481 to 2241 1 to 768       768/963
(79 %)
26 diff
(97.4 %id)
BU736037 eye, fetal eyes .j 1489 to 2068 596 to 17   AAA   580/580
(100 %)
1 diff
(99.9 %id)
AW007108 colon .j 1505 to 2067 564 to 2       563/564
(99 %)
0 diff
(100 %id)
BF212499 bone marrow, from chronic myelogenous leukemia .j 1535 to 2066 1 to 529   AAA   529/529
(100 %)
3 diff
(99.5 %id)
AW001421 colon, colonic mucosa from 3 patients with Crohn'sdisease .j 1551 to 2069 523 to 5       519/523
(99 %)
0 diff
(100 %id)
AW276541 lung, two pooled squamous cell carcinomas .j 1583 to 2074 492 to 1       492/492
(100 %)
0 diff
(100 %id)
DB527366 testis .j 1593 to 2066 1 to 474     Submitted on the opposite strand 474/474
(100 %)
4 diff
(99.2 %id)
DB542105 hippocampus .j 1593 to 2066 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
DB551937 hippocampus .j 1600 to 2066 1 to 468     Submitted on the opposite strand 468/468
(100 %)
2 diff
(99.6 %id)
BG121432 adenocarcinoma, cell line, Liver .j 1603 to 2353 1 to 742       742/938
(79 %)
13 diff
(98.7 %id)
DB521708 testis .j 1608 to 2068 1 to 461     Submitted on the opposite strand 461/461
(100 %)
2 diff
(99.6 %id)
BM672886 eye, optic nerve .j 1608 to 2066 477 to 19   AAA   459/459
(100 %)
0 diff
(100 %id)
TI_57168585   .j 1611 to 2074 25 to 488   AAA   464/488
(95 %)
6 diff
(98.8 %id)
AI570139 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 1631 to 2068 438 to 1       438/438
(100 %)
0 diff
(100 %id)
BG035115 adenocarcinoma, cell line, Liver .j 1637 to 2367 11 to 730       720/889
(80 %)
6 diff
(99.4 %id)
DB509420 testis .j 1646 to 2065 1 to 420     Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
BI085035 epidermoid carcinoma, cell line, salivary gland .j 1654 to 2317 676 to 1   fully sequenced,   676/676
(100 %)
22 diff
(96.8 %id)
BE348953 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .j 1658 to 2066 409 to 1       409/409
(100 %)
0 diff
(100 %id)
CN421593 embryonic stem cells, DMSO-treated H9 cellline .j 1682 to 1988 1 to 307   AAA   307/307
(100 %)
0 diff
(100 %id)
BM721702 eye, fetal eye .j 1682 to 2032 1 to 351       351/351
(100 %)
0 diff
(100 %id)
TI_149298150   .j 1700 to 2375 761 to 89   AAA   673/694
(96 %)
7 diff
(99.0 %id)
AA632262 breast .j 1721 to 2066 360 to 15   AAA   346/346
(100 %)
0 diff
(100 %id)
AI377105   .j 1731 to 2068 348 to 11   AAA   338/338
(100 %)
0 diff
(100 %id)
BU684519 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 1731 to 2375 663 to 19   tiling clone, AAA   645/645
(100 %)
1 diff
(99.9 %id)
T33558 brain .j 1737 to 2066 330 to 1       330/330
(100 %)
0 diff
(100 %id)
AI590399 adenocarcinoma, Pancreas .j 1752 to 2068 333 to 17   AAA   317/317
(100 %)
0 diff
(100 %id)
AA761883 germinal center B cell .j 1771 to 1992 252 to 31   AAA   222/222
(100 %)
0 diff
(100 %id)
CN421590 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 1774 to 2366 1 to 594       594/594
(100 %)
5 diff
(99.2 %id)
TI_154135515   .j 1800 to 2367 677 to 107       571/873
(65 %)
0 diff
(100 %id)
BG034787 adenocarcinoma, cell line, Liver .j 1817 to 2367 1 to 550   AAA   550/550
(100 %)
2 diff
(99.7 %id)
BQ447717 Knee, Osteoarthritic Cartilage .j 1822 to 2367 564 to 19   AAA   546/546
(100 %)
2 diff
(99.7 %id)
BI084606 epidermoid carcinoma, cell line, salivary gland .j 1850 to 2318 480 to 9       472/670
(70 %)
0 diff
(100 %id)
TI_154135516   .j 1862 to 2367 616 to 108       509/900
(56 %)
0 diff
(100 %id)
GD137354   .j 1874 to 2067 1 to 194       194/209
(92 %)
4 diff
(98.1 %id)
GD143584   .j 1874 to 2071 1 to 198       198/205
(96 %)
3 diff
(98.6 %id)
GD138012   .j 1914 to 2067 1 to 154       154/169
(91 %)
2 diff
(98.9 %id)
BF589300 pooled .j 1955 to 2367 433 to 21   AAA   413/413
(100 %)
3 diff
(99.3 %id)
CD671721 eye, Iris .j 2000 to 2375 416 to 41       376/416
(90 %)
0 diff
(100 %id)
BX329927 Placenta Cot 25-normalized .j 2032 to 2365 334 to 1       334/405
(82 %)
19 diff
(95.4 %id)
BX396005 Placenta Cot 25-normalized .j 2054 to 2318 268 to 1       748/927
(80 %)
58 diff
(93.8 %id)
AI354615 Kidney, renal cell tumor .j 2054 to 2367 333 to 22   AAA   312/312
(100 %)
1 diff
(99.7 %id)
AI522330 Kidney .j 2059 to 2374 335 to 20   AAA   316/316
(100 %)
0 diff
(100 %id)
AI625306 adenocarcinoma, Pancreas .j 2152 to 2367 254 to 39   AAA   216/216
(100 %)
6 diff
(97.3 %id)
R09759 liver and spleen .j 2155 to 2375 250 to 31   AAA   220/220
(100 %)
4 diff
(98.2 %id)
AA629281   .j 2242 to 2582 1 to 339     Submitted on the opposite strand 339/339
(100 %)
11 diff
(96.8 %id)
DB514429.
matches multiple genes
testis .j 2248 to 2691 444 to 1     also hits gene FARP2 444/444
(100 %)
6 diff
(98.7 %id)
DB521589.
matches multiple genes
testis .j 2248 to 2703 457 to 2   tiling clone, also hits gene FARP2 456/457
(99 %)
0 diff
(100 %id)
DB524819.
matches multiple genes
testis .j 2248 to 2723 476 to 1   tiling clone, also hits gene FARP2 476/476
(100 %)
1 diff
(99.8 %id)
DB525370.
matches multiple genes
testis .j 2248 to 2634 387 to 1     also hits gene FARP2 387/387
(100 %)
2 diff
(99.5 %id)
H14391 whole brain .j 2353 to 2735 21 to 409       389/474
(82 %)
6 diff
(98.8 %id)
BG028403 Bone, osteosarcoma, cell line .j 2558 to 3091 1 to 540   tiling clone,   540/540
(100 %)
26 diff
(95.2 %id)
BM153061 leukopheresis .j 2858 to 3213 1 to 356   tiling clone,   356/356
(100 %)
15 diff
(95.8 %id)
CT003615 T-Lymphocytes .j 3084 to 3921 9 to 846   tiling clone,   838/846
(99 %)
6 diff
(99.3 %id)
AL135616 melanoma (MeWo cell line) .j 3128 to 3629 495 to 1   tiling clone, Submitted on the opposite strand 495/495
(100 %)
14 diff
(97.2 %id)
H14342 whole brain .j 3738 to 4196 481 to 11   tiling clone, AAA   471/475
(99 %)
7 diff
(98.6 %id)
DA314818 hippocampus .j 3802 to 4344 2 to 546   tiling clone, capped   545/545
(100 %)
3 diff
(99.5 %id)
AI565858 anaplastic oligodendroglioma, brain .j 3905 to 4203 298 to 1       298/299
(99 %)
1 diff
(99.7 %id)
AI333974 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 3979 to 4418 441 to 2       440/441
(99 %)
0 diff
(100 %id)
AW015007   .j 3988 to 4412 442 to 18   AAA   425/425
(100 %)
3 diff
(99.3 %id)
DA778895 brain .j 4061 to 4635 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BQ935255 brain, neuroblastoma, cell line .j 4166 to 4961 1 to 798   tiling clone,   798/968
(82 %)
9 diff
(99.1 %id)
BQ918769 brain, neuroblastoma, cell line .j 4166 to 5011 1 to 852   tiling clone,   852/936
(91 %)
13 diff
(98.7 %id)
BG831435 epithelioid carcinoma cell line, Pancreas .k 1 to 858 1 to 852   tiling clone,   852/854
(99 %)
33 diff
(96.2 %id)
BQ689886 ductal carcinoma, cell line, Pancreas .k 74 to 906 27 to 865   tiling clone,   839/918
(91 %)
17 diff
(98.2 %id)
TI_59395264   .k 74 to 774 62 to 775       714/721
(99 %)
28 diff
(96.2 %id)
BU185640 ductal carcinoma, cell line, Pancreas .k 75 to 891 1 to 827       827/912
(90 %)
21 diff
(97.7 %id)
BU150326 ductal carcinoma, cell line, Pancreas .k 75 to 897 1 to 832       832/928
(89 %)
37 diff
(96.1 %id)
BQ689078 ductal carcinoma, cell line, Pancreas .k 75 to 895 1 to 827   tiling clone,   827/880
(93 %)
11 diff
(98.8 %id)
BQ687422 ductal carcinoma, cell line, Pancreas .k 75 to 897 1 to 833   tiling clone,   833/906
(91 %)
16 diff
(98.3 %id)
BQ691013 ductal carcinoma, cell line, Pancreas .k 75 to 916 1 to 851   tiling clone,   851/879
(96 %)
13 diff
(98.6 %id)
TI_59395265   .k 1204 to 1773 603 to 22   tiling clone,   582/606
(96 %)
1 diff
(99.9 %id)
BF312152 brain, neuroblastoma .l 1 to 789 1 to 788   tiling clone,   788/958
(82 %)
21 diff
(97.9 %id)
BI195677 brain, neuroblastoma .l 1 to 861 1 to 864   tiling clone,   862/864
(99 %)
22 diff
(97.5 %id)
BE260164 brain, neuroblastoma .l 20 to 512 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
BG684469 B-cells, primary B-cells from tonsils (cell line) .l 601 to 1304 1 to 703   tiling clone,   703/703
(100 %)
2 diff
(99.8 %id)
BI115593 lung, small cell carcinoma .l 853 to 1724 1 to 865   tiling clone,   865/866
(99 %)
14 diff
(98.4 %id)
BE292820 adenocarcinoma cell line, colon .m 1 to 591 1 to 591   tiling clone,   591/591
(100 %)
0 diff
(100 %id)
CR984362 T-Lymphocytes .m 525 to 977 1 to 453   tiling clone,   453/453
(100 %)
0 diff
(100 %id)
CN421591 embryonic stem cells, cell lines H1, H7, andH9 .n 1 to 644 1 to 644   tiling clone,   644/644
(100 %)
1 diff
(99.9 %id)
BI193376 epithelioid carcinoma cell line, Pancreas .n 113 to 805 1 to 695       695/695
(100 %)
8 diff
(98.9 %id)
BI194316 epithelioid carcinoma cell line, Pancreas .n 113 to 903 1 to 796 V223G R224A W225L R226E S227E ...     796/797
(99 %)
12 diff
(98.5 %id)
BE908683 epithelioid carcinoma, Pancreas .n 212 to 816 1 to 616       614/1018
(60 %)
28 diff
(97.3 %id)
BM193268 leukopheresis .n 487 to 1039 552 to 1   tiling clone,   552/552
(100 %)
7 diff
(98.8 %id)
DA946519 Spleen .o 1 to 572 2 to 577   tiling clone, capped   576/576
(100 %)
5 diff
(99.2 %id)
BM562111 leukocyte .o 418 to 1380 21 to 997   tiling clone,   977/1126
(86 %)
37 diff
(96.8 %id)
DB254521 uterus .o 628 to 1139 2 to 515   capped   514/514
(100 %)
2 diff
(99.7 %id)
DA304818 hippocampus .o 800 to 1376 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BF206799 brain, neuroblastoma .o 859 to 1360 1 to 501       501/501
(100 %)
2 diff
(99.7 %id)
BI200058 brain, neuroblastoma .o 859 to 1402 1 to 541       541/541
(100 %)
13 diff
(97.6 %id)
CR623111 adult brain .o 921 to 2944 1 to 2024 exact tiling clone,   2024/2024
(100 %)
0 diff
(100 %id)
AL532921 adult brain, brain .o 921 to 1959 1 to 1022       1022/1022
(100 %)
19 diff
(98.2 %id)
CT003641 T-Lymphocytes .o 1254 to 1901 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
CN347827 embryonic stem cells, cell lines H1, H7, andH9 .o 1391 to 2061 1 to 671       671/671
(100 %)
5 diff
(99.3 %id)
CT003825 T-Lymphocytes .o 1392 to 2149 1 to 761       761/763
(99 %)
4 diff
(99.5 %id)
AA167723   .o 1418 to 1932 87 to 589     Submitted on the opposite strand 503/616
(81 %)
26 diff
(95.8 %id)
BF205536 muscle, rhabdomyosarcoma .o 1453 to 2177 1 to 721       719/721
(99 %)
16 diff
(97.8 %id)
BF205819 muscle, rhabdomyosarcoma .o 1453 to 2162 1 to 707       707/742
(95 %)
20 diff
(97.4 %id)
BF203907 muscle, rhabdomyosarcoma .o 1453 to 2229 1 to 768       766/896
(85 %)
29 diff
(96.8 %id)
BF307000 muscle, rhabdomyosarcoma .o 1453 to 2276 1 to 823       819/902
(90 %)
31 diff
(96.6 %id)
BF307635 muscle, rhabdomyosarcoma .o 1453 to 2155 1 to 706       706/954
(74 %)
21 diff
(97.8 %id)
BF305674 muscle, rhabdomyosarcoma .o 1453 to 2162 1 to 703       701/949
(73 %)
15 diff
(98.5 %id)
BG825709 muscle, rhabdomyosarcoma .o 1453 to 1968 1 to 531       531/557
(95 %)
11 diff
(98.1 %id)
BG825271 muscle, rhabdomyosarcoma .o 1453 to 2347 1 to 887 L158C H159T S160V S161H Q162R ...     887/971
(91 %)
20 diff
(98.0 %id)
BG828267 muscle, rhabdomyosarcoma .o 1453 to 2152 1 to 695       695/700
(99 %)
7 diff
(99.0 %id)
BX453764 adult brain, brain .o 1457 to 2194 733 to 1       733/943
(77 %)
25 diff
(97.4 %id)
BE250300 muscle, rhabdomyosarcoma .o 1473 to 2009 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
BE250405 muscle, rhabdomyosarcoma .o 2084 to 2908 825 to 13       813/999
(81 %)
26 diff
(97.4 %id)
DB339963 testis .p-u 1 to 545 1 to 545   tiling clone, Submitted on the opposite strand 545/545
(100 %)
1 diff
(99.9 %id)
DA122940 cerebellum .p-u 154 to 707 2 to 556   tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
CD622522   .p-u 444 to 711 19 to 286   tiling clone,   268/286
(93 %)
6 diff
(98.0 %id)
BQ685326 ductal carcinoma, cell line, Pancreas .q 1 to 880 1 to 894 L105P G106X I107D T108H A109S ... tiling clone,   892/904
(98 %)
23 diff
(97.5 %id)
BG328962 eye, retinoblastoma .r 1 to 653 1 to 651   tiling clone,   651/803
(81 %)
15 diff
(98.2 %id)
BQ953426 epidermoid carcinoma, cell line, lung .r 600 to 1344 1 to 756       756/905
(83 %)
14 diff
(98.5 %id)
BQ876930 epidermoid carcinoma, cell line, lung .r 600 to 1254 1 to 657       657/1037
(63 %)
8 diff
(99.3 %id)
BQ925417 epidermoid carcinoma, cell line, lung .r 600 to 1316 1 to 724       724/794
(91 %)
10 diff
(98.8 %id)
BU528808 epidermoid carcinoma, cell line, lung .r 600 to 1481 1 to 887   tiling clone,   885/887
(99 %)
6 diff
(99.4 %id)
BQ960510 epidermoid carcinoma, cell line, lung .r 601 to 1434 1 to 841       841/1007
(83 %)
23 diff
(97.8 %id)
BQ367961 placenta_normal .r 709 to 1088 26 to 396       371/396
(93 %)
6 diff
(98.5 %id)
DA507257 brain .r 1191 to 1714 2 to 525   tiling clone, capped   524/524
(100 %)
1 diff
(99.9 %id)
AI003350 schizophrenic brain S-11 frontal lobe .r 1268 to 1649 381 to 2       380/382
(99 %)
0 diff
(100 %id)
CN421607 embryonic stem cells, DMSO-treated H9 cellline .r 1400 to 1695 1 to 296       296/296
(100 %)
1 diff
(99.7 %id)
CD513250 brain, Pituitary .r 1492 to 2309 13 to 841   tiling clone,   829/917
(90 %)
43 diff
(95.4 %id)
BM153033 leukopheresis .r 1872 to 2353 482 to 1       482/487
(98 %)
16 diff
(96.8 %id)
CK430483 eye, lacrimal gland .r 1879 to 2493 1 to 615   tiling clone,   615/615
(100 %)
0 diff
(100 %id)
TI_151795950   .r 1879 to 2599 121 to 842       722/821
(87 %)
32 diff
(96.2 %id)
BG327021 Kidney, renal cell adenocarcinoma .r 1892 to 2631 1 to 738       738/739
(99 %)
6 diff
(99.2 %id)
CT003004 T-Lymphocytes .r 1902 to 2332 1 to 431       431/431
(100 %)
0 diff
(100 %id)
BF310476 brain, neuroblastoma .r 1910 to 2615 1 to 706       706/1021
(69 %)
13 diff
(98.8 %id)
CR621330 thymus .r 1913 to 2742 1 to 830       830/830
(100 %)
0 diff
(100 %id)
BX436323 thymus .r 1913 to 2742 1 to 830   fully sequenced,   830/830
(100 %)
3 diff
(99.7 %id)
TI_45133745   .r 1913 to 2770 58 to 912       855/864
(98 %)
36 diff
(95.9 %id)
BE244688 leukopheresis .r 1925 to 2353 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
BQ671040 epidermoid carcinoma, cell line, salivary gland .r 1935 to 2783 1 to 861       861/862
(99 %)
28 diff
(96.8 %id)
BE272035 adenocarcinoma cell line, ovary .r 1936 to 2417 1 to 482       482/482
(100 %)
0 diff
(100 %id)
BE244689 leukopheresis .r 1937 to 2353 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
BF237491 leiomyosarcoma cell line, uterus .r 1938 to 2712 1 to 764       764/818
(93 %)
16 diff
(98.1 %id)
BF237459 leiomyosarcoma cell line, uterus .r 1939 to 2697 1 to 757       757/761
(99 %)
14 diff
(98.2 %id)
BF685527 leiomyosarcoma cell line, uterus .r 1939 to 2723 1 to 784       784/1016
(77 %)
27 diff
(97.4 %id)
BF971560 leiomyosarcoma cell line, uterus .r 1939 to 2780 1 to 832       832/865
(96 %)
34 diff
(96.1 %id)
BF973077 leiomyosarcoma cell line, uterus .r 1939 to 2770 1 to 822       822/923
(89 %)
34 diff
(96.4 %id)
BF973890 leiomyosarcoma cell line, uterus .r 1939 to 2752 1 to 811       811/1114
(72 %)
44 diff
(96.1 %id)
BG337636 leiomyosarcoma cell line, uterus .r 1939 to 2736 1 to 794       794/799
(99 %)
14 diff
(98.3 %id)
BX383183   .r 1955 to 2803 1 to 848   tiling clone,   848/848
(100 %)
2 diff
(99.8 %id)
TI_57182333   .r 1956 to 2779 68 to 893       826/893
(92 %)
17 diff
(98.1 %id)
BI771972 pooled lung and spleen .r 1957 to 2779 1 to 825       825/825
(100 %)
12 diff
(98.6 %id)
BE244325 leukopheresis .r 1961 to 2353 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
BE242159 leukopheresis .r 1971 to 2353 382 to 1       382/382
(100 %)
5 diff
(98.7 %id)
BQ674771 epidermoid carcinoma, cell line, salivary gland .r 1975 to 2774 1 to 806       806/866
(93 %)
16 diff
(98.2 %id)
BU197213 epidermoid carcinoma, cell line, salivary gland .r 1975 to 2731 1 to 769       769/903
(85 %)
20 diff
(97.8 %id)
BQ960322 epidermoid carcinoma, cell line, lung .r 1975 to 2718 1 to 745       745/963
(77 %)
7 diff
(99.3 %id)
BU527607 epidermoid carcinoma, cell line, lung .r 1975 to 2840 1 to 872   tiling clone,   872/876
(99 %)
16 diff
(98.2 %id)
BU162674 melanotic melanoma, cell line, skin .r 1976 to 2820 1 to 860   tiling clone,   860/862
(99 %)
27 diff
(96.9 %id)
BM153183 leukopheresis .r 1977 to 2353 378 to 1       378/380
(99 %)
11 diff
(97.2 %id)
BE242170 leukopheresis .r 1982 to 2353 373 to 1       373/373
(100 %)
7 diff
(98.2 %id)
BE241723 leukopheresis .r 1983 to 2353 370 to 1       370/370
(100 %)
5 diff
(98.7 %id)
BX436322 thymus .r 2475 to 2742 268 to 1   fully sequenced,   268/268
(100 %)
1 diff
(99.7 %id)
AK302751 testis .s 1 to 1029 1 to 1029 exact tiling clone,   1029/1029
(100 %)
0 diff
(100 %id)
CN421596 embryonic stem cells, cell lines H1, H7, andH9 .s 98 to 760 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
CN421598 embryonic stem cells, cell lines H1, H7, andH9 .s 149 to 701 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BM149550 leukopheresis .s 261 to 797 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BM144991 leukopheresis .s 261 to 895 1 to 635       635/635
(100 %)
3 diff
(99.6 %id)
BM145529 leukopheresis .s 261 to 745 1 to 485       485/485
(100 %)
6 diff
(98.8 %id)
BM193510 leukopheresis .s 261 to 778 1 to 519       519/519
(100 %)
6 diff
(98.9 %id)
BM151068 leukopheresis .s 261 to 724 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BE245400 leukopheresis .s 261 to 851 1 to 589       589/589
(100 %)
6 diff
(99.0 %id)
BE245671 leukopheresis .s 261 to 662 1 to 404       404/433
(93 %)
1 diff
(99.8 %id)
BE246841 leukopheresis .s 261 to 673 1 to 414       414/436
(94 %)
5 diff
(98.9 %id)
BM151345 leukopheresis .s 261 to 698 1 to 439       439/439
(100 %)
3 diff
(99.4 %id)
BM151359 leukopheresis .s 261 to 672 1 to 413       413/453
(91 %)
6 diff
(98.7 %id)
BM151561 leukopheresis .s 261 to 680 1 to 422       422/442
(95 %)
4 diff
(99.1 %id)
CR987716 T-Lymphocytes .s 476 to 973 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
CN421592 embryonic stem cells, cell lines H1, H7, andH9 .s 634 to 953 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
CR936874 testis .s 779 to 5720 1 to 4941   tiling clone, AAA   4941/4941
(100 %)
1 diff
(100.0 %id)
BX509563   .s 779 to 1117 1 to 339       339/339
(100 %)
6 diff
(98.3 %id)
BF310713 brain, neuroblastoma .s 785 to 1377 1 to 593       593/958
(61 %)
22 diff
(97.8 %id)
BE382921 brain, neuroblastoma .s 807 to 1518 1 to 716       716/778
(92 %)
31 diff
(96.1 %id)
BE166291 head_neck .s 822 to 1349 13 to 540       528/540
(97 %)
6 diff
(98.9 %id)
DB082837 testis .s 824 to 1388 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA869720 Prostate .s 901 to 1443 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA620933   .s 941 to 1520 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CB215954 normal endometrium, late proliferativephase, cycle day 13, uterus .s 1026 to 1637 1 to 612       612/612
(100 %)
0 diff
(100 %id)
DB116121 thymus .s 1053 to 1381 2 to 330   capped   329/329
(100 %)
1 diff
(99.7 %id)
BQ777866 Pancreas, Purified pancreatic islet .s 1084 to 1517 1 to 435       435/444
(97 %)
21 diff
(95.3 %id)
BM693835 eye, lens .s 1121 to 1657 1 to 537       537/537
(100 %)
0 diff
(100 %id)
T69066 Liver .s 1235 to 1564 2 to 331       330/408
(80 %)
10 diff
(97.6 %id)
AW390068 stomach .s 1379 to 1715 1 to 339       339/339
(100 %)
15 diff
(95.6 %id)
BQ712053 Spleen .s 4137 to 4905 17 to 791       775/928
(83 %)
11 diff
(98.9 %id)
BQ708092 Spleen .s 4140 to 4939 1 to 803       803/922
(87 %)
9 diff
(99.1 %id)
CN288089 embryonic stem cells, cell lines H1, H7, andH9 .s 4387 to 4930 1 to 545       545/546
(99 %)
2 diff
(99.7 %id)
DR423357 eye, Pterygium .s 4581 to 5300 1 to 720       720/720
(100 %)
2 diff
(99.8 %id)
BM670897 eye, lens .s 5081 to 5716 654 to 19   AAA   636/636
(100 %)
1 diff
(99.9 %id)
BX509564   .s 5108 to 5720 632 to 20   AAA   613/613
(100 %)
0 diff
(100 %id)
DB329845 Prostate .s 5154 to 5718 565 to 1       565/565
(100 %)
3 diff
(99.5 %id)
BQ777567 Pancreas, Purified pancreatic islet .s 5319 to 5717 402 to 4       399/402
(99 %)
0 diff
(100 %id)
T68988 Liver .s 5443 to 5712 268 to 3       266/268
(99 %)
0 diff
(100 %id)
BQ716326 sympathetic trunk .t 1 to 620 7 to 630 G183A K190* tiling clone,   630/1011
(62 %)
13 diff
(98.8 %id)
TI_159676632   .u 1 to 953 48 to 982 N119X P132X K133X K148X L155S ... tiling clone,   935/1049
(89 %)
24 diff
(97.8 %id)
CF132386 Chondrosarcoma Lung Metastasis cell lines, lung .u 3 to 698 1 to 697   tiling clone,   697/697
(100 %)
5 diff
(99.3 %id)
BU174854 ductal carcinoma, cell line, Pancreas .u 89 to 788 1 to 706   tiling clone,   706/947
(74 %)
11 diff
(98.9 %id)
BU149602 ductal carcinoma, cell line, Pancreas .u 89 to 789 1 to 704   tiling clone,   704/952
(73 %)
10 diff
(99.0 %id)
BQ685885 ductal carcinoma, cell line, Pancreas .u 89 to 720 1 to 637       637/1071
(59 %)
23 diff
(97.9 %id)
BQ688644 ductal carcinoma, cell line, Pancreas .u 89 to 722 1 to 638   tiling clone,   638/984
(64 %)
21 diff
(97.9 %id)
BM144573 leukopheresis .va 1 to 463 1 to 463 exact tiling clone,   463/464
(99 %)
1 diff
(99.8 %id)
BM151210 leukopheresis .va 1 to 441 1 to 440       440/441
(99 %)
13 diff
(97.1 %id)
DA308182 hippocampus .vb 1 to 560 2 to 562 exact tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BM153348 leukopheresis .vb 219 to 765 1 to 547   tiling clone,   547/547
(100 %)
5 diff
(99.1 %id)
BM151003 leukopheresis .vb 219 to 663 1 to 446       446/446
(100 %)
7 diff
(98.5 %id)
DA492111 brain .vc 1 to 574 2 to 575 S105F tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
DB142362 thymus .vd 1 to 501 4 to 504 exact tiling clone, capped   503/503
(100 %)
4 diff
(99.3 %id)
BY797726 eye .vd 490 to 1000 1 to 511   tiling clone,   511/511
(100 %)
0 diff
(100 %id)
DA087699 cerebellum .ve -8 to 565 2 to 576 exact tiling clone, capped   575/575
(100 %)
2 diff
(99.7 %id)
T03735   .vf 1 to 455 455 to 1 exact tiling clone,   455/465
(97 %)
6 diff
(98.8 %id)
AA635369   .vg-u 1 to 423 8 to 429   tiling clone,   422/429
(98 %)
6 diff
(98.7 %id)
BQ710872 Spleen .vg-u 410 to 1293 2 to 894 S57P tiling clone,   893/1012
(88 %)
6 diff
(99.5 %id)
DA533895 brain .vh 1 to 568 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA355607 subthalamic nucleus .vi 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
AI582166 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .vj-u 1 to 559 559 to 1 T26A tiling clone,   559/559
(100 %)
1 diff
(99.9 %id)
AW452685   .vj-u 74 to 558 484 to 1 T26A L46S E47R A48P W49G ...     484/484
(100 %)
5 diff
(99.0 %id)
CR995195 T-Lymphocytes .vk 1 to 515 1 to 515 exact tiling clone,   515/516
(99 %)
1 diff
(99.9 %id)
DB300209 cerebellum Gene STK25, variant not shown              
DA116338 cerebellum Gene STK25, variant not shown       capped      
DA811083 brain Gene STK25, variant not shown       capped      
TI_149286048   Gene STK25, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_149315028   Gene STK25, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg-u, .vh, .vi, .vj-u, .vk Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI